<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
<journal-id journal-id-type="publisher-id">nar</journal-id>
<journal-title-group>
<journal-title>Nucleic Acids Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0305-1048</issn>
<issn pub-type="epub">1362-4962</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30698754</article-id>
<article-id pub-id-type="pmc">6412123</article-id>
<article-id pub-id-type="doi">10.1093/nar/gkz011</article-id>
<article-id pub-id-type="publisher-id">gkz011</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Survey and Summary</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Matching tRNA modifications in humans to their known and predicted enzymes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>de Crécy-Lagard</surname>
<given-names>Valérie</given-names>
</name>
<!--<email>vcrecy@ufl.edu</email>-->
<xref ref-type="aff" rid="AFF1">1</xref>
<xref ref-type="aff" rid="AFF2">2</xref>
<xref ref-type="corresp" rid="COR1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boccaletto</surname>
<given-names>Pietro</given-names>
</name>
<xref ref-type="aff" rid="AFF3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mangleburg</surname>
<given-names>Carl G</given-names>
</name>
<xref ref-type="aff" rid="AFF1">1</xref>
<xref ref-type="corresp" rid="COR5"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharma</surname>
<given-names>Puneet</given-names>
</name>
<xref ref-type="aff" rid="AFF4">4</xref>
<xref ref-type="aff" rid="AFF5">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-3253-6021</contrib-id>
<name>
<surname>Lowe</surname>
<given-names>Todd M</given-names>
</name>
<!--<email>tmjlowe@ucsc.edu</email>-->
<xref ref-type="aff" rid="AFF6">6</xref>
<xref ref-type="corresp" rid="COR2"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-0523-6325</contrib-id>
<name>
<surname>Leidel</surname>
<given-names>Sebastian A</given-names>
</name>
<!--<email>sebastian.leidel@dcb.unibe.ch</email>-->
<xref ref-type="aff" rid="AFF4">4</xref>
<xref ref-type="aff" rid="AFF5">5</xref>
<xref ref-type="aff" rid="AFF7">7</xref>
<xref ref-type="corresp" rid="COR3"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-6633-165X</contrib-id>
<name>
<surname>Bujnicki</surname>
<given-names>Janusz M</given-names>
</name>
<!--<email>iamb@genesilico.pl</email>-->
<xref ref-type="aff" rid="AFF3">3</xref>
<xref ref-type="aff" rid="AFF8">8</xref>
<xref ref-type="corresp" rid="COR4"></xref>
</contrib>
</contrib-group>
<aff id="AFF1"><label>1</label>Department of Microbiology and Cell Sciences, University of Florida, Gainesville, FL 32611, USA</aff>
<aff id="AFF2"><label>2</label>Cancer and Genetic Institute, University of Florida, Gainesville, FL 32611, USA</aff>
<aff id="AFF3"><label>3</label>Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology, ul. Trojdena 4, 02-109 Warsaw, Poland</aff>
<aff id="AFF4"><label>4</label>Max Planck Research Group for RNA Biology, Max Planck Institute for Molecular Biomedicine, 48149 Muenster, Germany</aff>
<aff id="AFF5"><label>5</label>Cells-in-Motion Cluster of Excellence, University of Muenster, 48149 Muenster, Germany</aff>
<aff id="AFF6"><label>6</label>Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA</aff>
<aff id="AFF7"><label>7</label>Research Group for RNA Biochemistry, Institute of Chemistry and Biochemistry, University of Bern, 3012 Bern, Switzerland</aff>
<aff id="AFF8"><label>8</label>Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, ul. Umultowska 89, 61-614 Poznań, Poland</aff>
<author-notes>
<corresp id="COR1">To whom correspondence should be addressed. Tel: +1 352 392 9416; Fax: +1 352 392 5922; Email: <email>vcrecy@ufl.edu</email></corresp>
<corresp id="COR2">Correspondence may also be addressed to Todd Lowe. Tel: +1 831 459 1511; Email: <email>tmjlowe@ucsc.edu</email></corresp>
<corresp id="COR3">Correspondence may also be addressed to Sebastian Leidel. Tel: +41 31 6314296; Email: <email>sebastian.leidel@dcb.unibe.ch</email></corresp>
<corresp id="COR4">Correspondence may also be addressed to Janusz Bujnicki. Tel: +48 22 597 0750; Fax: +48 22 597 0715; Email: <email>iamb@genesilico.pl</email></corresp>
<corresp id="COR5">Present address: Carl G. Mangleburg, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>18</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-01-30" pub-type="epub">
<day>30</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>30</day>
<month>1</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>47</volume>
<issue>5</issue>
<fpage>2143</fpage>
<lpage>2159</lpage>
<history>
<date date-type="accepted">
<day>10</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>12</month>
<year>2018</year>
</date>
<date date-type="received">
<day>05</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri xlink:href="gkz011.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>tRNA are post-transcriptionally modified by chemical modifications that affect all aspects of tRNA biology. An increasing number of mutations underlying human genetic diseases map to genes encoding for tRNA modification enzymes. However, our knowledge on human tRNA-modification genes remains fragmentary and the most comprehensive RNA modification database currently contains information on approximately 20% of human cytosolic tRNAs, primarily based on biochemical studies. Recent high-throughput methods such as DM-tRNA-seq now allow annotation of a majority of tRNAs for six specific base modifications. Furthermore, we identified large gaps in knowledge when we predicted all cytosolic and mitochondrial human tRNA modification genes. Only 48% of the candidate cytosolic tRNA modification enzymes have been experimentally validated in mammals (either directly or in a heterologous system). Approximately 23% of the modification genes (cytosolic and mitochondrial combined) remain unknown. We discuss these ‘unidentified enzymes’ cases in detail and propose candidates whenever possible. Finally, tissue-specific expression analysis shows that modification genes are highly expressed in proliferative tissues like testis and transformed cells, but scarcely in differentiated tissues, with the exception of the cerebellum. Our work provides a comprehensive up to date compilation of human tRNA modifications and their enzymes that can be used as a resource for further studies.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>GM70641</award-id>
<award-id>HG006753</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">European Research Council</named-content>
<named-content content-type="funder-identifier">10.13039/501100000781</named-content>
</funding-source>
<award-id>310489</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">German Research Foundation</named-content>
<named-content content-type="funder-identifier">10.13039/501100001659</named-content>
</funding-source>
<award-id>SPP 1784</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Polish National Science Centre</named-content>
<named-content content-type="funder-identifier">10.13039/501100004281</named-content>
</funding-source>
<award-id>2012/04/A/NZ2/00455</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="17"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="SEC1" sec-type="intro">
<title>INTRODUCTION</title>
<p>The acquisition of post-transcriptional chemical modifications is an essential part of the maturation process required to generate functional tRNA molecules (<xref ref-type="bibr" rid="B1">1</xref>). Modifications have different roles in controlling stability, folding and decoding properties of tRNAs and can be determinants or anti-determinants for other components of the translation apparatus like e.g. aminoacyl-tRNA synthetases (<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>). In addition, tRNA modifications can be recognition elements of ribonucleases (<xref ref-type="bibr" rid="B4">4</xref>), leading to the generation of tRNA fragments that affect multiple cellular processes (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>However, very few modifications such as m<sup>1</sup>G37, Ψ55 or t<sup>6</sup>A37 are present at a specific position of a particular tRNA in (almost) all known organisms. Most of them are specific to particular taxons, from species to kingdoms. For example, lysidine (k<sup>2</sup>C34) is a hallmark of bacteria (<xref ref-type="bibr" rid="B6">6</xref>), while archaeosine (G<sup>+</sup>15) is only found in archaea (<xref ref-type="bibr" rid="B7">7</xref>). Depending on the organism, the total number of genes encoding tRNA modification enzymes varies between as little as eleven in some obligate symbionts (<xref ref-type="bibr" rid="B8">8</xref>) to around an estimated hundred in humans of which 50 are currently represented in MODOMICS (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>The near complete sets of tRNA modification genes are currently available for only one organism per domain of life: <italic>Saccharomyces cerevisiae</italic> for eukarya, where only one gene required for the formation of ncm<sup>5</sup>U out of cm<sup>5</sup>U is missing (<xref ref-type="bibr" rid="B10">10</xref>), <italic>Escherichia coli</italic> for bacteria where only the genes for ho<sup>5</sup>U34 and Acp<sup>3</sup>U47-formation remain unidentified and <italic>Haloferax volcanii</italic> for archaea where a handful of genes are missing (<xref ref-type="bibr" rid="B1">1</xref>). Beyond these three organisms, the annotation of tRNA modification genes remains scarce, because of several issues: First, RNA modification enzymes are often part of large multifunctional protein families such as the Rossmann Fold Methyltransferase (RFM) superfamily, which can act on other substrates than RNA (<xref ref-type="bibr" rid="B11">11</xref>). For example, some RNA methyltransferases are closely related to protein methyltransferases or DNA methyltransferases (<xref ref-type="bibr" rid="B11">11</xref>). Second, closely related members of orthologous families often introduce a similar chemical modification, but in different RNAs and at different positions. For example, members of the TrmFO family methylate tRNA or rRNA depending on the organism (<xref ref-type="bibr" rid="B12">12</xref>). Third, related enzymes can generate chemically distinct modifications. For example closely related Radical-SAM enzymes introduce methyl groups at different positions of nucleosides like in m<sup>2</sup>A or m<sup>8</sup>A (<xref ref-type="bibr" rid="B13">13</xref>). Finally, the same chemical modification, in particular methyl groups, can be introduced by proteins that are dissimilar (<xref ref-type="bibr" rid="B14">14</xref>) or even evolutionarily unrelated having arisen through non-orthologous gene displacements (<xref ref-type="bibr" rid="B15">15</xref>). For example, the formation of the universal m<sup>1</sup>G37 is catalyzed by TrmD and Trm5, two enzymes of completely different evolutionary origins in bacteria and in eukarya/archaea (<xref ref-type="bibr" rid="B16">16</xref>). The combination of these factors has made it difficult to identify enzymes responsible for many tRNA modifications and hence to determine the function of those tRNA modifications in many species including humans.</p>
<p>Recently, an increasing number of mutations causing genetic diseases have been mapped to human genes encoding tRNA modification enzymes (see (<xref ref-type="bibr" rid="B17">17–22</xref>) and Table <xref ref-type="table" rid="tbl1">1</xref>), making a comprehensive list of these genes highly desirable. However, to our knowledge, no complete compilation of modifications found in both cytosolic and mitochondrial human tRNAs with their corresponding predicted or validated modification enzymes is available. For mitochondria, the best approximation is a recent list of modifications of bovine tRNAs and the predicted enzymes (<xref ref-type="bibr" rid="B23">23</xref>), which has been extrapolated for human tRNAs (<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>). A prediction of human tRNA methyltransferases, based on the known yeast enzymes was performed more than five years ago (<xref ref-type="bibr" rid="B25">25</xref>) and was recently extended to homologs of the other yeast RNA modification genes (<xref ref-type="bibr" rid="B26">26</xref>). Surveys of specific enzyme families such as the human m<sup>5</sup>C methyltransferases (<xref ref-type="bibr" rid="B27">27</xref>) or pseudouridine synthases (<xref ref-type="bibr" rid="B28">28</xref>) that target tRNA molecules have listed the known and missing genes for these specific modifications. The goal of our analysis was to compile a comprehensive list of known and predicted tRNA modifications in <italic>Homo sapiens</italic> with genes implicated in their biosynthesis. This analysis allowed for the identification of the remaining gaps of knowledge in the field of human tRNA modifications and will help to guide future experiments. Furthermore, we have used publicly available datasets in order to determine the expression profiles and proteomic evidence of known and predicted modification enzymes. Our work will facilitate access to the current knowledge on human tRNA modification enzymes for a wider community of biologists.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>Known and predicted tRNA modification genes that have been linked to human diseases</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1">Modification</th>
<th colspan="1" rowspan="1">Gene</th>
<th colspan="1" rowspan="1">Disease</th>
<th colspan="1" rowspan="1">Cyto. Pheno.</th>
<th colspan="1" rowspan="1">Mito. Pheno.</th>
<th colspan="1" rowspan="1">Article</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">xG</td>
<td colspan="1" rowspan="1">
<bold>THG1L</bold>
</td>
<td colspan="1" rowspan="1">Microcephaly, developmental delay, nephrotic defect</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B110">110</xref>,<xref ref-type="bibr" rid="B175">175</xref>,<xref ref-type="bibr" rid="B176">176</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>1</sup>G</td>
<td colspan="1" rowspan="1">
<bold>TRMT10A</bold>
</td>
<td colspan="1" rowspan="1">Diabetes, intellectual disabilities, microcephaly, developmental defects</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B111">111</xref>,<xref ref-type="bibr" rid="B143">143</xref>,<xref ref-type="bibr" rid="B177">177–180</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">ac<sup>4</sup>C</td>
<td colspan="1" rowspan="1">
<bold>NAT10</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B112">112</xref>,<xref ref-type="bibr" rid="B181">181</xref>,<xref ref-type="bibr" rid="B182">182</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">ac<sup>4</sup>C</td>
<td colspan="1" rowspan="1">
<bold>THUMPD1</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B113">113</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gm</td>
<td colspan="1" rowspan="1">
<bold>TARBP1</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B114">114</xref>,<xref ref-type="bibr" rid="B115">115</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">D</td>
<td colspan="1" rowspan="1">
<bold>DUS2</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B116">116</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Y</td>
<td colspan="1" rowspan="1">
<bold>PUS1</bold>
</td>
<td colspan="1" rowspan="1">Mitochondrial myopathy and sideroblastic anemia (MLASA)</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B117">117</xref>,<xref ref-type="bibr" rid="B183">183</xref>,<xref ref-type="bibr" rid="B184">184</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>3</sup>C</td>
<td colspan="1" rowspan="1">
<bold>METTL6</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B118">118</xref>,<xref ref-type="bibr" rid="B119">119</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">I</td>
<td colspan="1" rowspan="1">
<bold>ADAT3</bold>
</td>
<td colspan="1" rowspan="1">Intellectual disabilities, microcephaly</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B120">120</xref>,<xref ref-type="bibr" rid="B185">185–187</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>5</sup>C</td>
<td colspan="1" rowspan="1">
<bold>NSUN2</bold>
</td>
<td colspan="1" rowspan="1">Intellectual disabilities, developmental delay, reduced fertility, cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B121">121</xref>,<xref ref-type="bibr" rid="B170">170–172</xref>,<xref ref-type="bibr" rid="B189">189</xref>,<xref ref-type="bibr" rid="B229">229–232</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">C<sub>m</sub>,U<sub>m</sub>,G<sub>m</sub>, f<sup>5</sup>C<sub>m</sub>, hm<sup>5</sup>C<sub>m</sub>, mcm<sup>5</sup>U<sub>m</sub></td>
<td colspan="1" rowspan="1">
<bold>FTSJ1</bold>
</td>
<td colspan="1" rowspan="1">Intellectual disabilities</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B122">122</xref>,<xref ref-type="bibr" rid="B123">123</xref>,<xref ref-type="bibr" rid="B188">188</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">C<sub>m</sub>, G<sub>m</sub>,f<sup>5</sup>C<sub>m</sub>, hm<sup>5</sup>C<sub>m</sub></td>
<td colspan="1" rowspan="1">
<bold>WDR6</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B124">124</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Q</td>
<td colspan="1" rowspan="1">
<bold>QTRT1</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B125">125</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">cm<sup>5</sup>U, ncm<sup>5</sup>U, mcm<sup>5</sup>U, mcm<sup>5</sup>s2U</td>
<td colspan="1" rowspan="1">
<bold>ELP1</bold>
</td>
<td colspan="1" rowspan="1">Familial dysautonomia, cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B126">126</xref>,<xref ref-type="bibr" rid="B127">127</xref>,<xref ref-type="bibr" rid="B190">190</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">cm<sup>5</sup>U, ncm<sup>5</sup>U, mcm<sup>5</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>ELP3</bold>
</td>
<td colspan="1" rowspan="1">Familial dysautonomia, Charcot–Marie–Tooth disease (CMT), cancer, amyotrophic lateral sclerosis (ALS)</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B127">127</xref>,<xref ref-type="bibr" rid="B130">130</xref>,<xref ref-type="bibr" rid="B191">191</xref>,<xref ref-type="bibr" rid="B192">192</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">cm<sup>5</sup>U, ncm<sup>5</sup>U, mcm<sup>5</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>ELP4</bold>
</td>
<td colspan="1" rowspan="1">Autism spectrum disorder, intellectual disabilities</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B128">128</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">cm<sup>5</sup>U, ncm<sup>5</sup>U, mcm<sup>5</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>ELP5</bold>
</td>
<td colspan="1" rowspan="1">Cancer, diabetes</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B129">129</xref>,<xref ref-type="bibr" rid="B193">193</xref>,<xref ref-type="bibr" rid="B194">194</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">s<sup>2</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>CTU1</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B127">127</xref>,<xref ref-type="bibr" rid="B130">130</xref>,<xref ref-type="bibr" rid="B131">131</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">s<sup>2</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>CTU2</bold>
</td>
<td colspan="1" rowspan="1">Microcephaly, nephrotic defect, cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B127">127</xref>,<xref ref-type="bibr" rid="B130">130</xref>,<xref ref-type="bibr" rid="B132">132</xref>,<xref ref-type="bibr" rid="B133">133</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">s<sup>2</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>MOCS3*</bold>
</td>
<td colspan="1" rowspan="1">Molybdenum cofactor deficiency</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">s<sup>2</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>MPST*</bold>
</td>
<td colspan="1" rowspan="1">Mercaptolactate-cysteine disulfiduria (MCDU), intellectual disabilities</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">s<sup>2</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>NFS1*</bold>
</td>
<td colspan="1" rowspan="1">Friedreich ataxia</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">s<sup>2</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>SERGEF*</bold>
</td>
<td colspan="1" rowspan="1">Hereditary deafness, artheriosclerosis</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">s<sup>2</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>CIAO1*</bold>
</td>
<td colspan="1" rowspan="1">Hereditary paraganglioma-pheochromocytoma syndromes, retinitis pigmentosa</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">s<sup>2</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>NUBP1*</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">s<sup>2</sup>U, mcm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>ISCU*</bold>
</td>
<td colspan="1" rowspan="1">Myopathy with lactic acidosis, Friedreich ataxia</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">I</td>
<td colspan="1" rowspan="1">
<bold>ADAT1</bold>
</td>
<td colspan="1" rowspan="1">Coronary artery disease</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B134">134</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>1</sup>G, m<sup>1</sup>I</td>
<td colspan="1" rowspan="1">
<bold>TRMT5</bold>
</td>
<td colspan="1" rowspan="1">Failure to thrive, hypertrophic cardiomyopathy, exercise intolerance</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B135">135</xref>,<xref ref-type="bibr" rid="B136">136</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">o2Yw, yW</td>
<td colspan="1" rowspan="1">
<bold>TRMT12</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B137">137</xref>,<xref ref-type="bibr" rid="B138">138</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">o2Yw, yW</td>
<td colspan="1" rowspan="1">
<bold>LCMT2</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B139">139</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">t<sup>6</sup>A</td>
<td colspan="1" rowspan="1">
<bold>YRDC</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B140">140</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">t<sup>6</sup>A</td>
<td colspan="1" rowspan="1">
<bold>OSGEP</bold>
</td>
<td colspan="1" rowspan="1">Galloway-Mowat syndrome, microcephaly, nephrotic defects</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B141">141</xref>,<xref ref-type="bibr" rid="B195">195–197</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">t<sup>6</sup>A</td>
<td colspan="1" rowspan="1">
<bold>TP53RK</bold>
</td>
<td colspan="1" rowspan="1">Galloway-Mowat syndrome, microcephaly, nephrotic defects, cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B141">141</xref>,<xref ref-type="bibr" rid="B142">142</xref>,<xref ref-type="bibr" rid="B195">195</xref>,<xref ref-type="bibr" rid="B196">196</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">t<sup>6</sup>A</td>
<td colspan="1" rowspan="1">
<bold>TPRKB</bold>
</td>
<td colspan="1" rowspan="1">Galloway-Mowat syndrome, microcephaly, nephrotic defects</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B141">141</xref>,<xref ref-type="bibr" rid="B195">195</xref>,<xref ref-type="bibr" rid="B196">196</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">t<sup>6</sup>A</td>
<td colspan="1" rowspan="1">
<bold>LAGE3</bold>
</td>
<td colspan="1" rowspan="1">Galloway-Mowat syndrome, microcephaly, nephrotic defects</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B141">141</xref>,<xref ref-type="bibr" rid="B195">195</xref>,<xref ref-type="bibr" rid="B196">196</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">ms<sup>2</sup>t<sup>6</sup>A</td>
<td colspan="1" rowspan="1">
<bold>CDKAL1</bold>
</td>
<td colspan="1" rowspan="1">Diabetes, microcephaly, cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B144">144</xref>,<xref ref-type="bibr" rid="B198">198</xref>,<xref ref-type="bibr" rid="B199">199</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>5</sup>C</td>
<td colspan="1" rowspan="1">
<bold>TRDMT1</bold>
</td>
<td colspan="1" rowspan="1">Metabolism, cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B145">145</xref>,<xref ref-type="bibr" rid="B146">146</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Y</td>
<td colspan="1" rowspan="1">
<bold>PUS3</bold>
</td>
<td colspan="1" rowspan="1">Intellectual disabilities</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B147">147</xref>,<xref ref-type="bibr" rid="B148">148</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Um</td>
<td colspan="1" rowspan="1">
<bold>TRMT44</bold>
</td>
<td colspan="1" rowspan="1">Partial Epilepsy with Pericentral Spikes (PEPS)</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B149">149</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>7</sup>G</td>
<td colspan="1" rowspan="1">
<bold>METTL1</bold>
</td>
<td colspan="1" rowspan="1">Multiple sclerosis, cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B150">150</xref>,<xref ref-type="bibr" rid="B200">200</xref>,<xref ref-type="bibr" rid="B201">201</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>7</sup>G</td>
<td colspan="1" rowspan="1">
<bold>WDR4</bold>
</td>
<td colspan="1" rowspan="1">Microcephaly, cancer, nephrotic defects, developmental defects</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B151">151</xref>,<xref ref-type="bibr" rid="B202">202–204</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>5</sup>U</td>
<td colspan="1" rowspan="1">
<bold>TRMT2A</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B152">152</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Y</td>
<td colspan="1" rowspan="1">
<bold>PUS10</bold>
</td>
<td colspan="1" rowspan="1">Autoimmune diseases, intellectual disabilities</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B153">153</xref>,<xref ref-type="bibr" rid="B205">205</xref>,<xref ref-type="bibr" rid="B206">206</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>1</sup>A</td>
<td colspan="1" rowspan="1">
<bold>TRMT6</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B139">139</xref>,<xref ref-type="bibr" rid="B154">154</xref>,<xref ref-type="bibr" rid="B155">155</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>1</sup>A</td>
<td colspan="1" rowspan="1">
<bold>TRMT61A</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B139">139</xref>,<xref ref-type="bibr" rid="B154">154</xref>,<xref ref-type="bibr" rid="B155">155</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>5</sup>C</td>
<td colspan="1" rowspan="1">
<bold>NSUN6*</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B156">156</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>1</sup>G,m<sup>1</sup>A</td>
<td colspan="1" rowspan="1">
<bold>TRMT10C</bold>
</td>
<td colspan="1" rowspan="1">Lactic acidosis, hypotonia, feeding difficulties, deafness</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B157">157</xref>,<xref ref-type="bibr" rid="B158">158</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>1</sup>G,m<sup>1</sup>A</td>
<td colspan="1" rowspan="1">
<bold>HSD17B10</bold>
</td>
<td colspan="1" rowspan="1">Neurodegeneration, cardiomyopathy</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B158">158</xref>,<xref ref-type="bibr" rid="B207">207</xref>,<xref ref-type="bibr" rid="B208">208</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>2,2</sup>G</td>
<td colspan="1" rowspan="1">
<bold>TRMT1</bold>
</td>
<td colspan="1" rowspan="1">Intellectual disabilities, microcephaly</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B159">159</xref>,<xref ref-type="bibr" rid="B209">209</xref>,<xref ref-type="bibr" rid="B210">210</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">f<sup>5</sup>C</td>
<td colspan="1" rowspan="1">
<bold>NSUN3</bold>
</td>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B160">160</xref>,<xref ref-type="bibr" rid="B161">161</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">tm<sup>5</sup>U</td>
<td colspan="1" rowspan="1">
<bold>GTPBP3</bold>
</td>
<td colspan="1" rowspan="1">Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), non-syndromic hearing loss</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B162">162</xref>,<xref ref-type="bibr" rid="B163">163</xref>,<xref ref-type="bibr" rid="B211">211–213</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">tm<sup>5</sup>U</td>
<td colspan="1" rowspan="1">
<bold>MTO1</bold>
</td>
<td colspan="1" rowspan="1">Lactic acidosis, cardiomyopathy, encephalopathy, non-syndromic hearing loss, cancer, myoclonus epilepsy associated with ragged-red fibers (MERRF)</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B162">162–164</xref>,<xref ref-type="bibr" rid="B214">214–217</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">tm<sup>5</sup>s<sup>2</sup>U</td>
<td colspan="1" rowspan="1">
<bold>TRMU</bold>
</td>
<td colspan="1" rowspan="1">Leigh syndrome, hepatopathy associated with hyperlactatemia, non-syndromic hearing loss</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B165">165</xref>,<xref ref-type="bibr" rid="B218">218–222</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">t6A</td>
<td colspan="1" rowspan="1">
<bold>OSGEPL1</bold>
</td>
<td colspan="1" rowspan="1">Cancer, MERRF</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B166">166</xref>,<xref ref-type="bibr" rid="B167">167</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">i6A</td>
<td colspan="1" rowspan="1">
<bold>TRIT1</bold>
</td>
<td colspan="1" rowspan="1">Microcephaly, developmental delay, epilepsy, cancer</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B168">168</xref>,<xref ref-type="bibr" rid="B223">223–225</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">ms2i6A</td>
<td colspan="1" rowspan="1">
<bold>CDK5RAP1</bold>
</td>
<td colspan="1" rowspan="1">Cancer, type II diabetes, vitiligo</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B169">169</xref>,<xref ref-type="bibr" rid="B226">226–228</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">m<sup>1</sup>A</td>
<td colspan="1" rowspan="1">
<bold>TRMT61B</bold>
</td>
<td colspan="1" rowspan="1">Cancer, Alzheimer's disease</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">(<xref ref-type="bibr" rid="B173">173</xref>,<xref ref-type="bibr" rid="B174">174</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="T1TFN1">
<p>*Disease likely caused by defects other than loss of tRNA modification.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="SEC2" sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<p>The set of human isoacceptor tRNAs (i.e. tRNAs that are acylated with the same amino acid regardless of the anticodon sequence) was extracted from the Genomic tRNA Database (GtRNAdb): <ext-link ext-link-type="uri" xlink:href="http://gtrnadb.ucsc.edu/">http://gtrnadb.ucsc.edu/</ext-link> (<xref ref-type="bibr" rid="B29">29</xref>) and is summarized here: <ext-link ext-link-type="uri" xlink:href="http://gtrnadb.ucsc.edu/genomes/eukaryota/Hsapi19/">http://gtrnadb.ucsc.edu/genomes/eukaryota/Hsapi19/</ext-link></p>
<p>All modifications present in the sequences of cytosolic and mitochondrial tRNA of human (<italic>H. sapiens</italic>), cow (<italic>Bos taurus</italic>), rat (<italic>Rattus norvegicus</italic>), and mouse (<italic>Mus musculus</italic>) were extracted from the MODOMICS database of RNA modification pathways (<ext-link ext-link-type="uri" xlink:href="http://modomics.genesilico.pl/">http://modomics.genesilico.pl/</ext-link>) (<xref ref-type="bibr" rid="B9">9</xref>). This provided a first list that was then updated with one modification from the literature (m<sup>5</sup>C34 in Leu-CAA-tRNA) and several human modifications detected with novel tRNAseq methods (<xref ref-type="bibr" rid="B30">30</xref>) (m<sup>3</sup>C20 in Met-CAU-tRNA and m<sup>3</sup>C47 in Leu-CAG-tRNA and most Ser-tRNAs, m<sup>1</sup>A16 in mito-Arg-TCG-tRNA and m<sup>3</sup>C32 in mito-Thr-UGU-tRNA and mito-Ser-UGA) that were missing from MODOMICS. The MODOMICS database was updated accordingly.</p>
<p>High-throughput tRNA-seq modification data was derived from published study data sets (<xref ref-type="bibr" rid="B30">30–32</xref>). The protein and literature mining tools of NCBI (<xref ref-type="bibr" rid="B33">33</xref>) as well as the Uniprot resource and Id/Mapping tools (<xref ref-type="bibr" rid="B34">34</xref>) were used to gather data. Gene names were gathered from the HUGO Gene Nomenclature Committee (<ext-link ext-link-type="uri" xlink:href="https://www.genenames.org">https://www.genenames.org</ext-link>) (<xref ref-type="bibr" rid="B35">35</xref>). Protein interaction data was derived from BioGrid (<xref ref-type="bibr" rid="B36">36</xref>) and the predicted mitochondrial localization from MitoCarta (<ext-link ext-link-type="uri" xlink:href="https://www.broadinstitute.org/files/shared/metabolism/mitocarta/human.mitocarta2.0.html">https://www.broadinstitute.org/files/shared/metabolism/mitocarta/human.mitocarta2.0.html</ext-link>) (<xref ref-type="bibr" rid="B37">37</xref>).</p>
<p>Human co-expression data was extracted from the Search-based Exploration of Expression Compendium (SEEK) database (<ext-link ext-link-type="uri" xlink:href="http://seek.princeton.edu/index.jsp">http://seek.princeton.edu/index.jsp</ext-link>) (<xref ref-type="bibr" rid="B38">38</xref>). Phylogenetic trees for specific protein families were extracted from PhylomeDB (<ext-link ext-link-type="uri" xlink:href="http://phylomedb.org">http://phylomedb.org</ext-link>) (<xref ref-type="bibr" rid="B39">39</xref>). For gene expression analyses, RNAseq data was obtained from the GTEx portal (<ext-link ext-link-type="uri" xlink:href="http://www.gtexportal.org">www.gtexportal.org</ext-link>; GTEx_Analysis_2016-01-15_v7_RNASeQCv1.1.8_gene_tpm.gct.gz) on 30/04/2018. For each gene the transcript with the highest expression levels was selected for each tissue. Subsequently, relative expression levels were calculated and plotted as a heatmap using the heatmap.2 function in R. Tissues included in the analysis were selected to provide a general physiological overview. Hierarchical clustering of genes was performed according to similarity of expression profile using Ward's method (<xref ref-type="bibr" rid="B40">40</xref>). For tissue-specific proteomics evidence, we used the human proteome map (<ext-link ext-link-type="uri" xlink:href="http://www.humanproteomemap.org/">http://www.humanproteomemap.org/</ext-link>) using the default settings (<xref ref-type="bibr" rid="B41">41</xref>). Proteins that were not detected in any tissue were manually removed.</p>
</sec>
<sec id="SEC3" sec-type="results">
<title>RESULTS AND DISCUSSION</title>
<sec id="SEC3-1">
<title>Compiling all mammalian cytosolic tRNA modifications</title>
<p>As a first step to predict the complete set of modification enzymes, we sought to list the nature and positions of all chemical modifications that have been identified in human cytosolic tRNAs. This task is not trivial as the set of human tRNAs used in decoding is very complex (see (<xref ref-type="bibr" rid="B42">42</xref>) for a recent review). Indeed, not all tRNA sequences encoded in the human genome are expressed in common cell-lines (<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>). Based on the loss of canonical secondary structure, mutations at highly conserved positions, or positioning in transcriptional silent chromosomal regions, some candidate tRNA genes are likely tRNA-derived Short Interspersed Nuclear Elements or pseudogenes, and others may have non-canonical functions outside of translation (<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B46">46</xref>). Therefore, additional filtering criteria are needed to select a list of tRNAs that <italic>most likely</italic> decode mRNAs in the human cytosol. An updated set of ‘high confidence’ human tRNAs has been generated by tRNAscan-SE 2.0 (Chan, Lin and Lowe, unpublished data) and is available in the GtRNAdb (<xref ref-type="bibr" rid="B29">29</xref>). This list of over 400 tRNA genes contains 47 distinct isoacceptors families (including tRNA<sup>Sec</sup>, the tRNA for selenocysteine insertion).</p>
<p>A first set of biochemically-determined tRNA isoacceptor sequences that include chemical modifications in at least one mammal was extracted from the MODOMICS database at the time of the initial analysis (30 May 2017). Furthermore, partial information is available for modifications at specific positions such as wobble uridine (U34). It is known that 5-carbamoylmethyluridine (ncm<sup>5</sup>U) is found in Val-UAC-tRNA, 5-methoxycarbonylmethyl-2-thiouridine (mcm<sup>5</sup>s<sup>2</sup>U) in Arg-UCU-tRNA and 5-methoxycarbonyl-hydroxymethyluridine (mchm<sup>5</sup>U) in Gly-UCC-tRNA (<xref ref-type="bibr" rid="B47">47</xref>). Since the modifications of U34 in human Arg-UCU-tRNA and Gly-UCC-tRNA differ from those in the corresponding yeast tRNA, it is difficult to predict the nature of most of the U34 modifications in humans (<xref ref-type="bibr" rid="B48">48</xref>). Finally, a large fraction of the RNA sequence data stems from the 60s, 70s and 80s, so is based on paper and thin-layer chromatography (TLC) (<xref ref-type="bibr" rid="B49">49</xref>), photometric characterization of nucleosides following chromatography (<xref ref-type="bibr" rid="B50">50</xref>), and mass-spectrometry using low-resolution, low-sensitivity instruments (<xref ref-type="bibr" rid="B49">49</xref>). These methods failed to identify or distinguish some of the modifications, which are therefore listed as N and xN in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1A</xref> but can now be detected with high-resolution mass spectrometry (<xref ref-type="bibr" rid="B51">51–54</xref>).</p>
<p>To add to the complexity of the task, the human genome (in contrast to yeast) encodes isoacceptor families that include many unique isodecoders, which are tRNAs with the same anticodon but contains variations in the tRNA body (<xref ref-type="bibr" rid="B42">42</xref>). Different isodecoders can be expressed under specific conditions as shown for the neuron-specific tRNA-Arg-UCU (<xref ref-type="bibr" rid="B55">55</xref>) or in the case of cancer (<xref ref-type="bibr" rid="B56">56</xref>). New high-throughput sequencing methods have been developed and optimized to facilitate detection of full length tRNAs such as DM-tRNA-seq (<xref ref-type="bibr" rid="B31">31</xref>) or tRNA-HydroSeq (<xref ref-type="bibr" rid="B57">57</xref>) or AlkAniline-Seq (<xref ref-type="bibr" rid="B58">58</xref>) and of tRNA-derived small RNAs (ARM-seq (<xref ref-type="bibr" rid="B32">32</xref>)). While these high-throughput RNA modification mapping methods reviewed in (<xref ref-type="bibr" rid="B59">59</xref>) and (<xref ref-type="bibr" rid="B30">30</xref>) are not yet as precise or quantitative as mass spectrometry, they do offer a practical, inexpensive method to survey a subset of modifications across all expressed tRNAs for many cell types. Using these methods also offers a first glimpse of the diversity of modification states across different isodecoders. Some isodecoder families in human such as Ala-AGC can be highly complex, contrasting the relatively simple view previously seen in budding yeast. In human, there are 22 high confidence Ala-AGC tRNA genes detected in the genome, which encode 16 unique (by sequence) Ala-AGC tRNA transcripts; in yeast, there are 11 Ala-AGC genes, which all encode identical Ala-AGC tRNA transcripts. This variation in human tRNA sequences also leads to an apparent complexity in tRNA modifications that is only now being appreciated. For example, RNA modification data collected with traditional methods exists for just 2 out of 16 Ala-AGC isodecoders (Ala-AGC-8 and Ala-AGC-11). ARM-seq and DM-tRNA-seq, however, both detect transcripts and modifications for many more isodecoders (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S5</xref>). These high-throughput methods allowed to detect four human modifications that were missing in MODOMICS at the time of our first analysis (see methods section). The final count of tRNA isoacceptors with modification information is 27 in humans and 38 in mammals (Figure <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Tables S1A and S5</xref>).</p>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>tRNA isoacceptors that have been biochemically characterized at the RNA level by traditional methods. Three additional tRNA isoacceptors (Rn-Val-NAC, Hs-Leu-NAA, Hs-Val-NAC) listed in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1A</xref> weren’t placed in this figure due to their unknown nucleotide.</p>
</caption>
<graphic xlink:href="gkz011fig1"></graphic>
</fig>
</sec>
<sec id="SEC3-2">
<title>Linking the modifications of human cytosolic tRNAs to their corresponding modification enzymes</title>
<p>We generated a current list of chemical modifications found in human cytosolic tRNAs (Figure <xref ref-type="fig" rid="F2">2A</xref>, <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>) by combining the modification information from the tRNA sequences compiled in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1A</xref> Subsequently, we used this list as a starting point to generate the set of predicted human tRNA modification genes.</p>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p>Cloverleaf representation of tRNA, with modified positions indicated for (<bold>A</bold>) cytoplasmic and (<bold>B</bold>) mitochondrial tRNAs, respectively, indicating genes/proteins experimentally validated in human, predicted with high confidence in other species, unknown with predictions, and unknown with no predictions.</p>
</caption>
<graphic xlink:href="gkz011fig2"></graphic>
</fig>
<p>Once the list of human cytosolic tRNA modifications had been generated (Figure <xref ref-type="fig" rid="F2">2A</xref>, <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>), we linked the modifications to their corresponding modification enzymes whenever possible. This was done by using the advanced query tools of Uniprot for a first pass and then surveying the literature. By default, the reference linking the gene to the function is found by accessing the Uniprot entry for a given gene. Only when the reference had not yet been captured in Uniprot (∼10 cases), did we add a PMID entry in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>.</p>
<p>Not all predictions reach the same level of credibility. For example, in some cases, experimental validation is available for the human ortholog, while in other cases only the function of the yeast ortholog is validated. Therefore, we used the following code to classify the evidence of our functional annotation: [5] <italic>in vivo</italic> data in mammals; [4] <italic>in vivo</italic> data of the human or a related mammalian enzyme in a heterologous host; [3] <italic>in vitro</italic> data using the human enzyme; [2] similarity to an experimentally validated gene in a non-mammalian species; [1] candidates that have not been verified in any organism; [0] no clear candidate. These predictions are available in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>, and we summarized all enzymes with evidence codes 2–5 in Figure <xref ref-type="fig" rid="F2">2A</xref>, using the protein names recommended by the HUGO Gene Nomenclature committee (<xref ref-type="bibr" rid="B35">35</xref>). According to this assessment, we predicted at least 76 proteins to be required for the modification of cytosolic tRNAs. Clearly, this is an underestimation, as more than 24 enzymes are still unknown (evidence code 0 or 1). Furthermore, for approximately 26 proteins there is no direct <italic>in vivo</italic> or <italic>in vitro</italic> experimental data using a mammalian homolog (evidence code 2). Thus, our analysis emphasizes that extensive experimental validations and research will be required to verify specific gene predictions and to identify some of the ‘missing’ genes. These cases will be further discussed below.</p>
</sec>
<sec id="SEC3-3">
<title>Identifying candidates for the ‘missing’ genes</title>
<p>To identify candidates of unidentified tRNA modifications enzymes, we compiled an initial list of ∼40 human proteins that are members of families known to be implicated in RNA modifications. These were mainly methyltransferases, pseudouridine synthases or THUMP-domain-containing proteins that have not yet been linked to a specific function. When we surveyed the recent literature, we found that ∼2/3 of these candidates had been reported to modify rRNA or proteins. For the remaining twelve proteins/genes, we gathered localization data from Mitocarta, and analyzed co-expression using the SEEK expression database profiles to identify the candidates that are coexpressed with RNA processing or translation related genes (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>). This list is far from exhaustive as new methylase folds implicated in RNA modification are still being discovered (<xref ref-type="bibr" rid="B60">60</xref>).</p>
</sec>
<sec id="SEC3-4">
<title>Missing genes coding for cytosolic tRNA modification enzymes</title>
<p>In general, when the gene is missing, the function of the corresponding modification is very difficult to infer, as no genetic study can be conducted. In some cases, such as acp<sup>3</sup>U20, the gene is not known in any organism, and almost no functional information is available. The only functional inference that can be done is if the gene encoding the enzyme responsible for the same modification is known in another organism. This is the case for a few modifications such as m<sup>1</sup>A14 and m<sup>5</sup>U54 in yeast or m<sup>1</sup>G6 in bacteria and archaea. Also, for complex pathways in which some genes have already been characterized such as Q and mcm<sup>5</sup>s<sup>2</sup>U34, functional information is available. However, we feel it is a far stretch to transfer functional inferences made from prokaryotes or unicellular eukaryotes to human. Even if a related enzyme is known in another species, it is very difficult to predict how the unknown human enzyme discriminates substrate tRNAs from non-substrates. Thus, in the absence of information about the gene and enzyme responsible, very little information can be inferred about the function of the modification itself. Below we list modifications of human cytosolic tRNAs, for which the genes remain to be discovered and characterized, and this list also indicates the areas where functional information is missing.
<list list-type="bullet"><list-item><p><bold>m<sup>1</sup>G6/7</bold>: This nucleotide is modified in multiple cytosolic and in at least one mitochondrial tRNA (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1A and B</xref>). Trm14/TrmN are members of the COG0116 family of methyltransferases and target this position in several thermophilic bacteria and archaea (<xref ref-type="bibr" rid="B61">61</xref>). However other members of the same family, such as RmlL have been shown to methylate guanine residues in 23S RNA (<xref ref-type="bibr" rid="B62">62</xref>). THUMPD2 and THUMPD3 are two barely characterized members of this family in humans (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>), and previous analyses suggested that these enzymes might be required for the formation of both cytosolic and mitochondrial modifications (<xref ref-type="bibr" rid="B23">23</xref>). THUMPD2 was found to form a complex with the m<sup>2,2</sup>G26-methylase TRMT1, while THUMPD3 was shown to interact with the methylase-activator protein TRM112 (<xref ref-type="bibr" rid="B63">63</xref>) in two high-throughput interactome studies (<xref ref-type="bibr" rid="B36">36</xref>), strengthening their role as tRNA methyltransferase candidates. However, experimental verification will be required to evaluate whether these two proteins are essential for the formation of m<sup>1</sup>G, whether they exhibit different substrates specificities towards G6 or G7 and whether they act in mitochondria or in the cytoplasm.</p></list-item><list-item><p><bold>m<sup>1</sup>A14</bold>: Enzymes responsible for this modification were identified in <italic>S. cerevisiae</italic> and belong to the pfam01746 family (<xref ref-type="bibr" rid="B64">64</xref>). The human genome encodes three members of this family: TRMT10A is required for the generation of m<sup>1</sup>G9 in cytosolic tRNAs (<xref ref-type="bibr" rid="B65">65</xref>). TRMT10C as part of the RNase P complex, forms m<sup>1</sup>G9 in mitochondrial tRNAs (<xref ref-type="bibr" rid="B62">62</xref>) and like some family members from other species, can also methylate adenosine to form m<sup>1</sup>A9 (<xref ref-type="bibr" rid="B66">66</xref>). Hence, TRMT10B (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>) is a candidate for the elusive m<sup>1</sup>A14 methyltransferase, even if a recent report could not detect any tRNA methylation activity <italic>in vitro</italic> (<xref ref-type="bibr" rid="B67">67</xref>). As expected for a cytosolic enzyme, TRMT10B is not part of the predicted human mitoproteome (<xref ref-type="bibr" rid="B37">37</xref>). However, multiple reports of interactions with 25 mitochondrial ribosomal proteins (<ext-link ext-link-type="uri" xlink:href="https://thebiogrid.org/127659">https://thebiogrid.org/127659</ext-link>) suggest this protein localizes to the mitochondria. Further experiments will be needed to determine whether TRMT10B is the missing m<sup>1</sup>A14 methyltransferase or whether TRMT10A methylates both G9 and A14 or whether a yet unknown enzyme catalyzes this reaction.</p></list-item><list-item><p><bold>Acp<sup>3</sup>U20,20a</bold>: Only very few enzymes have been characterized that modify RNA by transferring the aminocarboxypropyl (acp) group of SAM, which is the methyl donor in most RNA-methylation reactions. However, acp-transferring enzymes belong to three unrelated superfamilies, which also contain methyltransferases. The only human enzyme currently known to introduce the acp<sup>3</sup> modification is TSR3, a member of the COG2042 family (<xref ref-type="bibr" rid="B68">68</xref>), which is required for the biosynthesis of the hypermodified nucleotide m<sup>1</sup>acp<sup>3</sup>Ψ in 18S rRNA (<xref ref-type="bibr" rid="B69">69</xref>). The crystal structures of its archaeal homologs revealed that TSR3 belongs to the SPOUT class of methyltransferases (<xref ref-type="bibr" rid="B69">69</xref>). The second structurally characterized acp-transferase Tyw2 belongs to the unrelated RFM superfamily (<xref ref-type="bibr" rid="B70">70</xref>). A different acp modification has been described in the diphthamide-biosynthesis pathway, where an acp group is transferred from SAM to the carbon atom of a histidine residue of eukaryotic translation elongation factor 2 (eEF2) by an enzyme that belongs to the Radical-SAM superfamily (<xref ref-type="bibr" rid="B71">71</xref>). acp<sup>3</sup>U is found in several positions in tRNA of different organisms like for example acp<sup>3</sup>U47 in <italic>E. coli</italic> tRNA, but the corresponding enzymes have not been identified in any of these species. Since all known acp transferases most likely arose independently from methyltransferases, the acp<sup>3</sup>U-forming enzyme may currently be annotated as a hypothetical methyltransferase of unknown function (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>) but it is difficult to select a plausible candidate in light of the diversity of known acp transferases.</p></list-item><list-item><p><bold>Ψ</bold>: The list of pseudouridine synthases modifying human tRNAs is far from complete. Several candidates have been proposed to be required for the modification of positions 30–32, 50, 72 or e11,12,13 (<xref ref-type="bibr" rid="B23">23</xref>), but several can likely be excluded as they were found to be required for the modification of mitochondrial rRNA and mito-tRNA at positions 27, 29, 39 and 50 (RPUSD4) (<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B72">72</xref>) or mitochondrial mRNA (like RPUSD3) (<xref ref-type="bibr" rid="B73">73</xref>). RPUSD1 and RPUSD2 (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>) have not been tested experimentally and are hence still valid candidates. Pus7/TruD, the enzyme that introduces Ψ13 is highly conserved in all three kingdoms (<xref ref-type="bibr" rid="B74">74</xref>) and is a member of the COG0585 family. The yeast Pus7 enzyme further modifies position 35 (<xref ref-type="bibr" rid="B75">75</xref>). PUS7 and PUS7L, two members of the COG0585 family in humans are products of a gene duplication that occurred most certainly in the common ancestors of metazoa (see <ext-link ext-link-type="uri" xlink:href="http://phylomedb.org/?q=search_tree&amp;seqid=Q9H0K6">http://phylomedb.org/?q=search_tree&amp;seqid=Q9H0K6</ext-link>). Experiments will be required to determine whether these two enzymes have identical, overlapping or different substrates specificities. For example, one of the two enzymes might modify position 13, while the second enzyme might target position 35. Another possibility is that PUS7 and PUS7L target both positions 13 and 35, but in different tRNA isoacceptors. PUS7 is implicated in pseudouridylation of Ψ8 in tRF derived from Ala-tRNA, Cys-tRNA and Val-tRNA but whether PUS7 acts directly on tRNA has formally not been shown (<xref ref-type="bibr" rid="B76">76</xref>). PUS1 is multisite specific so it is a plausible candidate for the positions 30 to 32, even though it has been found that the mouse homolog modifies positions 27, 28, 34 and 36 (<xref ref-type="bibr" rid="B77">77</xref>). Finally, based on experimental evidence from Archaea (<xref ref-type="bibr" rid="B78">78</xref>), it had been postulated that the human Pus10 is required for the formation of Ψ54 (<xref ref-type="bibr" rid="B28">28</xref>) and this was recently experimental validated in human (<xref ref-type="bibr" rid="B79">79</xref>).</p></list-item><list-item><p><bold>Q34</bold>: Queuosine in position 34 (Q34) is highly conserved in bacteria and eukarya. Humans like all eukaryotes are unable to synthesize Q but instead salvage the queuine (q) base from their diet and gut microflora as a micronutrient (<xref ref-type="bibr" rid="B80">80</xref>). Recent studies have shown that nutritionally determined Q-tRNA levels promote Dnmt2-mediated methylation of tRNA-Asp and control translational speed of Q-decoded codons as well as at near-cognate codons (<xref ref-type="bibr" rid="B81">81</xref>). The heterodimeric human TGT enzyme formed by the QTRT1 and QTRT2 (previously called QTRTD1) subunits is the only fully characterized enzyme of the Q salvage pathway (<xref ref-type="bibr" rid="B80">80</xref>). A second human salvage-enzyme member of the DUF2419 family has been identified but its molecular function is unknown (<xref ref-type="bibr" rid="B82">82</xref>). Finally, the transporter for the q base or the precursor nucleoside Q is still elusive as well as the enzyme(s) that further modify the Q residue by attaching galactosyl or mannosyl moieties.</p></list-item><list-item><p><bold>mcm<sup>5</sup>s<sup>2</sup>U34</bold>: Wobble uridine is generally modified in all known organisms (see (<xref ref-type="bibr" rid="B83">83</xref>) for a recent review). The combination of modifications at positions 2 and 5 of the nucleobase results in an intricate tuning of codon-anticodon interactions, thus allowing the translation apparatus to distinguish codons in split-codon boxes and to introduce additional amino acids (<xref ref-type="bibr" rid="B83">83</xref>,<xref ref-type="bibr" rid="B84">84</xref>). 5-carboxymethyluridine (cm<sup>5</sup>U), the first step of the 5-modification is introduced by the action of the Elongator complex, a heteromeric complex consisting of two copies of Elp1–Elp6 that is activated by several auxiliary proteins (<xref ref-type="bibr" rid="B85">85</xref>). Orthologs of all yeast Elongator complex subunits are known and described in humans. However, human orthologs of the yeast regulatory components (the kinase Kti14, the phosphatase Sit4 and its regulatory subunits Sap185 and Sap190) could not be identified. Here, functional screens will be required to determine the counterparts of these components in humans. The conversion of cm<sup>5</sup>U to mcm<sup>5</sup>U is catalyzed by the c-terminal Trm9 domain of ALKBH8 (<xref ref-type="bibr" rid="B86">86–88</xref>). mcm<sup>5</sup>U in some tRNA can be further hydroxylated to mchm<sup>5</sup>U by the AlkB Domain of ALKBH8 (<xref ref-type="bibr" rid="B87">87</xref>) or <italic>2</italic>′-<italic>O</italic>-methylated to mcm<sup>5</sup>Um by an unknown enzyme. The enzyme required for ncm<sup>5</sup>U formation from cm<sup>5</sup>U is not known in any organism and remains to be identified. 2-thiolation is achieved through the action of the URM1 pathway that shares features of bacterial sulfur-carrier proteins (SCP) and ubiquitin-like proteins (UBL) (<xref ref-type="bibr" rid="B89">89</xref>). The URM1 pathway components are straight forward to identify. Urm1 has two homologs in humans: URM1 and MOCS2A. However, MOCS2A is required for the synthesis of the molybdopterin cofactor while URM1 is required for tRNA thiolation and MOCS3 activates the SCP of both pathways (<xref ref-type="bibr" rid="B90">90</xref>). The final step of the thiolation reaction is performed by a complex consisting of CTU1 and CTU2.</p></list-item><list-item><p><bold>Missing methyltransferases</bold>. Methyltransferases are the biggest group of RNA modifying enzymes. While many tRNA methyltransferases have been discovered and characterized, a few of them remain to be identified (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>). Members of the NSUN family (PF01189) usually introduce m<sup>5</sup>C modifications (<xref ref-type="bibr" rid="B91">91</xref>) and some such as NSUN2 are multi-site specific (<xref ref-type="bibr" rid="B92">92</xref>). However, NSUN2 is not required for the formation of m<sup>5</sup>C40 or m<sup>5</sup>C72 (<xref ref-type="bibr" rid="B92">92</xref>). NSUN7 is the only member of the NSUN family without a known substrate (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>). Hence, it is a strong candidate for methylating one or both these positions. However, indirect data links it to methylation of enhancer RNAs (<xref ref-type="bibr" rid="B93">93</xref>). Three enzymes (METTL2A, METTL2B and METTL6) have been found to be involved in m<sup>3</sup>C32 formation potentially on different tRNA targets (<xref ref-type="bibr" rid="B94">94</xref>). Any of these three might be required for introducing m<sup>3</sup>C at position e2 and/or 47 as the biochemical assays have been inconclusive to date (See (<xref ref-type="bibr" rid="B94">94</xref>), <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S5</xref>). It is unclear, which protein synthesizes m<sup>5</sup>U54 since two human homologs of yeast Trm2 were identified: TRMT2A and TRMT2B (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>). It is not known whether these two proteins catalyze the same reaction or whether they differ in substrate specificity or sub-cellular localization. For example, TRMT2B is predicted to localize to mitochondria and might be required for modifying mitochondrial tRNAs (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). Finally, no candidate can easily be proposed for the formation of m<sup>1</sup>Ψ39, Ψm39 and Gm39. The pool of methyltransferase candidates among proteins with uncharacterized functions is large (∼8, <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>), and we did not find evidence to favor a specific candidate.</p></list-item></list></p>
</sec>
<sec id="SEC3-5">
<title>Identification of the genes encoding for mitochondrial tRNA modifications enzymes</title>
<p>The Suzuki laboratory published a thorough compilation of tRNA modification enzymes for the full set of 22 bovine mito-tRNAs (<xref ref-type="bibr" rid="B23">23</xref>) and most of their functional annotations can be transferred to orthologous human enzymes (Figure <xref ref-type="fig" rid="F2">2B</xref>, <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). Furthermore, some open cases have been solved since. Notably, ALKBH1 and NSUN3 are required for the formation of f<sup>5</sup>C in initiator tRNA (<xref ref-type="bibr" rid="B95">95–97</xref>). The same ALKBH1 enzyme is further required for hm<sup>5</sup>C and f<sup>5</sup>C formation in cytosolic tRNA (<xref ref-type="bibr" rid="B95">95</xref>). A more complete compilation of the predicted human mitochondrial tRNA modification enzymes was published recently with extensive added functional information (<xref ref-type="bibr" rid="B24">24</xref>). We compiled these predictions and added evidence codes resulting in a list of 35 enzymes required to modify the full set of mitochondrial tRNAs (Figure <xref ref-type="fig" rid="F2">2B</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). An additional evidence code to classify enzymes that have been experimentally validated in the cytoplasm but not in mitochondria was added (evidence code 6). We will discuss here the remaining open questions.</p>
<p>The Q base is found in mitochondrial tRNAs and the catalytic subunit QTRT1 of the human transglycosylase complex is found in the mitoproteome (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). In the cytoplasm, QTRT1 forms a complex with QTRT2 (<xref ref-type="bibr" rid="B98">98</xref>) but it is not known whether this interaction also occurs in mitochondria. It has been shown that QTRT1 and QTRT2 are associated with the mitochondria with QTRT2 more loosely bound than QTRT1 (<xref ref-type="bibr" rid="B99">99</xref>). Is it possible that QTRT2 facilitates the transport of q, as the mitochondrial queuine transporter is missing?</p>
<p>Similar to cytosolic pseudourine synthases, the set of enzymes introducing Ψ residues in mitochondrial tRNAs is far from complete, in particular since different enzymes can introduce the same modification at a given position in different tRNAs, implying that many more might be missing. RPUSD4 was recently shown to modify 16S rRNA from mitochondria and introduce Ψ39 in mito-tRNA<sup>Phe</sup> but not in mito-tRNA<sup>Gly</sup> (<xref ref-type="bibr" rid="B72">72</xref>). PUS3 was predicted to modify other mitochondrial tRNAs such as mito-tRNA<sup>Gln</sup> at position 39 (<xref ref-type="bibr" rid="B23">23</xref>). However, experimental data on PUS3 is available only for cytosolic tRNAs, requiring additional confirmation of its mitochondrial targets. Two pseudouridine synthases without known substrates (RPUSD3 and PUS1L) localize to the mitochondria (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>). RUPSD3 modifies mitochondrial mRNAs (<xref ref-type="bibr" rid="B73">73</xref>), leaving PUS1L as a strong candidate for an enzyme that modifies positions 30, 31, 50 and/or 57 (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>). Nevertheless, we cannot exclude that a pseudouridine synthase not predicted to be mitochondrial such as RPUSD1 or RPSUD2 is actually dually-targeted as it has been recently shown for Pus10 that is translocated to the mitochondria only under specific physiological conditions (<xref ref-type="bibr" rid="B100">100</xref>).</p>
<p>In general, the situation is more complex when one gene encodes for two proteins that localize to different sub-cellular compartments, since the mitochondria-targeted isoform is often not identified as a mitochondrial protein. Thirty- seven proteins are predicted to be required for mitochondrial tRNA modifications with nine of these currently unknown, and eleven modify only mitochondrial tRNAs (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). In the Mitocarta analysis that integrates 14 different sources of predictions and experimental data to compile a list 1158 human mitochondrial protein (<xref ref-type="bibr" rid="B37">37</xref>), ten of these proteins were correctly identified as mitochondrial (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). The only exception is CDK5RAP1, an enzyme required for the thiolation reaction during ms<sup>2</sup>i<sup>6</sup>A formation (<xref ref-type="bibr" rid="B101">101</xref>,<xref ref-type="bibr" rid="B102">102</xref>). Of the dually targeted proteins, ten were correctly assigned as mitochondrial in Mitocarta (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>) while seven others were not: TRM5, YRDC, PUS3, NSUN2, TRM112, METTL2B and QTRT2. TRM112 and QTRT2 are non-catalytic subunits and it cannot be excluded that they are dispensable in mitochondria, as tRNA modification machineries can be simpler in mitochondria. For example, only two proteins are required for the synthesis of t<sup>6</sup>A in mitochondria while six proteins are required in the cytosol (<xref ref-type="bibr" rid="B103">103</xref>). The case of PUS3 has already been discussed above. For the remaining three cases, dual localization data in yeast for Sua5p (<xref ref-type="bibr" rid="B104">104</xref>) and for Trm5p (<xref ref-type="bibr" rid="B105">105</xref>) as well as predicted isoforms (see <ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/uniprot/Q08J23">http://www.uniprot.org/uniprot/Q08J23</ext-link> for NSUN2) suggest that they can be similarly found in both compartments in humans. Hence, the MitoCarta set of mitochondrial proteins may be incomplete.</p>
<p>Finally, the enzymes required for the formation of m<sup>2</sup>G6, m<sup>5</sup>C72 and of several Ψ residues are experimentally uncharacterized (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). As discussed above, the two candidates for the formation of cytosolic m<sup>2</sup>G6 are THUMPD2 and THUMPD3. These two proteins are not predicted to localize to mitochondria (<xref ref-type="bibr" rid="B37">37</xref>) but this prediction might not be correct. The same is true for the candidate for the cytosolic m<sup>5</sup>C72 methylase, NSUN7.</p>
</sec>
<sec id="SEC3-6">
<title>Tissue expression and proteomics data of tRNA modification enzymes</title>
<p>Disease phenotypes of aberrant tRNA modification enzymes are often linked to neuronal phenotypes, metabolic disorders and cancer (<xref ref-type="bibr" rid="B17">17–21</xref>). However, the tissue-specific expression profiles of tRNA modification genes have not been systematically explored. Therefore, we used expression data available through the Genotype-Tissue-Expression (GTEx) project and compared expression levels of all modification genes in representative tissues of all organs (Figure <xref ref-type="fig" rid="F3">3</xref>). We also compiled tissue-specific proteomics evidence from the human proteome map (<xref ref-type="bibr" rid="B41">41</xref>) (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S1</xref>). Overall, there are several general trends: First, expression levels of modification genes are quite uniform between different tissues. Second, expression levels of most genes are relatively low, in particular in whole blood. Third, generally high expression levels are observed in testis and transformed cells. Fourth, expression levels in brain are below average of the tissues with the exception of the cerebellum, where expression of a small number of genes reaches levels that are similar to expression observed in testis. This is surprising given the typical neuronal phenotypes observed upon defects in human modification enzymes. There are, however, clusters of genes that are upregulated in several brain tissues (Figure <xref ref-type="fig" rid="F3">3</xref>). These findings may point to a more crucial function during early steps of differentiation and proliferation of stem cells. Thus, it is likely that many of the observed defects in humans are either developmental phenotypes or relatively subtle. Finally, even though most genes of different pathways are found in similar clusters, this is not true for all pathways, e.g. the ELP pathway. A similar trend is seen when analyzing the proteomics data (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S1</xref>). With the highly expressed genes, a correlation was observed between the transcriptomic and proteomics data (for example <italic>DUS2, PUS3</italic> or <italic>TRMT5</italic> in testis), however, the proteomic data is less complete due to the low expression levels of most enzymes (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S1</xref>). These observations suggest that tRNA modification enzymes are able to maintain sufficiently high modification levels in differentiated tissues likely because of the high stability of tRNA and low tRNA synthesis levels. Furthermore, some modification enzymes bind to RNA that are not their natural targets (See (<xref ref-type="bibr" rid="B106">106–109</xref>) for specific examples). Hence, it is likely beneficial to maintain low expression levels of these enzymes to avoid unspecific modification of cellular RNA like mRNA or rRNA.</p>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3.</label>
<caption>
<p>Expression of tRNA modification genes and candidates in a representative set of healthy human tissues. (<bold>A</bold>) Empirically selected tissues with physiological relevance are included. (<bold>B</bold>) Like (A), but only representing a set of brain tissues. Genes are clustered according to similarity in the expression profile. Source: <ext-link ext-link-type="uri" xlink:href="https://gtexportal.org">gtexportal.org</ext-link>. Genes included are from <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>.</p>
</caption>
<graphic xlink:href="gkz011fig3"></graphic>
</fig>
</sec>
</sec>
<sec id="SEC4" sec-type="conclusions">
<title>CONCLUSIONS</title>
<p>This inventory of human tRNA modifications and the corresponding enzymes surprisingly reveals that despite the fact that the field of RNA modifications has dramatically expanded in recent years with 50 human modifications enzymes identified only in the last 10 years, the picture is far from complete. We estimate that between ∼135 genes are required to modify cytosolic and mitochondrial tRNAs and that 23% of these genes still need to be identified and that another 22% require further experimental validations. Approximately 50% of the human modification genes have been linked to a number of human diseases (Table <xref ref-type="table" rid="tbl1">1</xref>). Furthermore, all genes required for the formation of iron-sulfur clusters affect tRNA modification indirectly and are linked to diseases that are likely not mediated by tRNA modification defects. Like described before (<xref ref-type="bibr" rid="B17">17–22</xref>) the phenotypes are most often neurodegenerative or neurodevelopmental diseases like microcephaly and intellectual disabilities, but also renal and metabolic defects. Finally, roughly 50% of the disease genes have been linked to cancer (Table <xref ref-type="table" rid="tbl1">1</xref>), suggesting that tRNA modification enzymes may provide interesting targets for cancer therapies. Also, given the wide diversity of tRNA transcript sequences in humans, the preference of different members of the modification enzyme families for different tRNA isodecoders remains an open question. An in-depth analysis of tRNA modification dynamics in various stress conditions and cell types will reveal the intimate relationship between tRNAs and their modifying partners in more detail. This compilation can act as a guide for future experiments to complete the characterization of the set of human tRNA modification enzymes.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="sup1">
<label>Supplementary Data</label>
<media xlink:href="gkz011_supplemental_files.zip">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="ACK1">
<title>ACKNOWLEDGEMENTS</title>
<p>We thank Yuri Motorin, Jane Jackman, Marc Graille, Vincent P. Kelly, Ramesh Gupta, Peter C. Dedon and Michaela Frye for inputs and discussions, and Michaela Frye for inspiring us for Figure <xref ref-type="fig" rid="F1">1</xref>. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH and NINDS.</p>
</ack>
<sec id="SEC5">
<title>SUPPLEMENTARY DATA</title>
<p>
<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkz011#supplementary-data">Supplementary Data</ext-link> are available at NAR Online.</p>
</sec>
<sec id="SEC6">
<title>FUNDING</title>
<p>National Institutes of Health [GM70641 to V. dC.-L; HG006753 to T.M.L.]; Max Planck Society and the European Research Council [310489-tRNAmodi to S.A.L.]; German Research Foundation [SPP 1784 to S.A.L.]; IIMCB statutory funds (to P.B. and J.M.B.); Polish National Science Centre [2012/04/A/NZ2/00455 to J.M.B]. The open access publication charge for this paper has been waived by Oxford University Press.</p>
<p>
<italic>Conflict of interest statement</italic>. Janusz M. Bujnicki is an Executive Editor of <italic>Nucleic Acids Research</italic>.</p>
</sec>
<ref-list id="REF1">
<title>REFERENCES</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>El Yacoubi</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Bailly</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>de Crécy-Lagard</surname><given-names>V.</given-names></name></person-group>
<article-title>Biosynthesis and function of posttranscriptional modifications of transfer RNAs</article-title>. <source/>Annu. Rev. Genet.<year>2012</year>; <volume>46</volume>:<fpage>69</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">22905870</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Agris</surname><given-names>P.F.</given-names></name>, <name name-style="western"><surname>Narendran</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sarachan</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Väre</surname><given-names>V.Y.P.</given-names></name>, <name name-style="western"><surname>Eruysal</surname><given-names>E.</given-names></name></person-group>
<article-title>The importance of being modified: The role of RNA modifications in translational fidelity</article-title>. <source/>Enzymes. <year>2017</year>; <volume>41</volume>:<fpage>1</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">28601219</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lorenz</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Lünse</surname><given-names>C.E.</given-names></name>, <name name-style="western"><surname>Mörl</surname><given-names>M.</given-names></name></person-group>
<article-title>tRNA modifications: impact on structure and thermal adaptation</article-title>. <source/>Biomolecules. <year>2017</year>; <volume>7</volume>:<fpage>35</fpage>.</mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chanfreau</surname><given-names>G.F.</given-names></name></person-group>
<article-title>Impact of RNA modifications and RNA-modifying enzymes on eukaryotic ribonucleases</article-title>. <source/>Enzymes. <year>2017</year>; <volume>41</volume>:<fpage>299</fpage>–<lpage>329</lpage>.<pub-id pub-id-type="pmid">28601225</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Cozen</surname><given-names>A.E.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Lowe</surname><given-names>T.M.</given-names></name></person-group>
<article-title>Small RNA modifications: integral to function and disease</article-title>. <source/>Trends Mol. Med.<year>2016</year>; <volume>22</volume>:<fpage>1025</fpage>–<lpage>1034</lpage>.<pub-id pub-id-type="pmid">27840066</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Numata</surname><given-names>T.</given-names></name></person-group>
<article-title>Convergent evolution of AUA decoding in bacteria and archaea</article-title>. <source/>RNA Biol.<year>2014</year>; <volume>11</volume>:<fpage>1586</fpage>–<lpage>1596</lpage>.<pub-id pub-id-type="pmid">25629511</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gregson</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Crain</surname><given-names>P.F.</given-names></name>, <name name-style="western"><surname>Edmonds</surname><given-names>C.G.</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hashizume</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Phillipson</surname><given-names>D.W.</given-names></name>, <name name-style="western"><surname>McCloskey</surname><given-names>J.A.</given-names></name></person-group>
<article-title>Structure of the archaeal transfer RNA nucleoside G*-15 (2-amino-4,7-dihydro- 4-oxo-7-beta-D-ribofuranosyl-1H-pyrrolo[2,3-d]pyrimidine-5-carboximi dam ide (archaeosine))</article-title>. <source/>J. Biol. Chem.<year>1993</year>; <volume>268</volume>:<fpage>10076</fpage>–<lpage>10086</lpage>.<pub-id pub-id-type="pmid">7683667</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gallo</surname><given-names>L.C.</given-names></name>, <name name-style="western"><surname>Penedo</surname><given-names>F.J.</given-names></name>, <name name-style="western"><surname>Carnethon</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Isasi</surname><given-names>C.R.</given-names></name>, <name name-style="western"><surname>Sotres-Alvarez</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Malcarne</surname><given-names>V.L.</given-names></name>, <name name-style="western"><surname>Roesch</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Youngblood</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Daviglus</surname><given-names>M.L.</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>P.</given-names></name><etal>et al</etal>.</person-group>
<article-title>The Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study: sample, design, and procedures</article-title>. <source/>Ethn. Dis.<year>2014</year>; <volume>24</volume>:<fpage>77</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">24620452</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Boccaletto</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Machnicka</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Purta</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Pitkowski</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Baginski</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Wirecki</surname><given-names>T.K.</given-names></name>, <name name-style="western"><surname>de Crécy-Lagard</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Limbach</surname><given-names>P.A.</given-names></name>, <name name-style="western"><surname>Kotter</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group>
<article-title>MODOMICS: a database of RNA modification pathways. 2017 update</article-title>. <source/>Nucleic Acids Res.<year>2018</year>; <volume>46</volume>:<fpage>D303</fpage>–<lpage>D307</lpage>.<pub-id pub-id-type="pmid">29106616</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>J.T.</given-names></name>, <name name-style="western"><surname>Byström</surname><given-names>A.S.</given-names></name></person-group>
<article-title>Unexpected accumulation of ncm(5)U and ncm(5)S(2) (U) in a trm9 mutant suggests an additional step in the synthesis of mcm(5)U and mcm(5)S(2)U</article-title>. <source/>PLoS One. <year>2011</year>; <volume>6</volume>:<fpage>e20783</fpage>.<pub-id pub-id-type="pmid">21687733</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bujnicki</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Comparison of protein structures reveals monophyletic origin of the AdoMet-dependent methyltransferase family and mechanistic convergence rather than recent differentiation of N4-cytosine and N6-adenine DNA methylation</article-title>. <source/>Silico Biol.<year>1999</year>; <volume>1</volume>:<fpage>175</fpage>–<lpage>182</lpage>.</mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lartigue</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Lebaudy</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Blanchard</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yacoubi</surname><given-names>B. El</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Grosjean</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Douthwaite</surname><given-names>S.</given-names></name></person-group>
<article-title>The flavoprotein Mcap0476 (RlmFO) catalyzes m5U1939 modification in Mycoplasma capricolum 23Ś rRNA</article-title>. <source/>Nucleic Acids Res.<year>2014</year>; <volume>42</volume>:<fpage>8073</fpage>–<lpage>8082</lpage>.<pub-id pub-id-type="pmid">24939895</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Fujimori</surname><given-names>D.G.</given-names></name></person-group>
<article-title>RNA methylation by Radical SAM enzymes RlmN and Cfr proceeds via methylene transfer and hydride shift</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.<year>2011</year>; <volume>108</volume>:<fpage>3930</fpage>–<lpage>3934</lpage>.<pub-id pub-id-type="pmid">21368151</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Husain</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Tkaczuk</surname><given-names>K.L.</given-names></name>, <name name-style="western"><surname>Tulsidas</surname><given-names>S.R.</given-names></name>, <name name-style="western"><surname>Kaminska</surname><given-names>K.H.</given-names></name>, <name name-style="western"><surname>Ĉubrilo</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Maravić-Vlahoviĉek</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Bujnicki</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Sivaraman</surname><given-names>J.</given-names></name></person-group>
<article-title>Structural basis for the methylation of G1405 in 16s rRNA by aminoglycoside resistance methyltransferase Sgm from an antibiotic producer: a diversity of active sites in m7G methyltransferases</article-title>. <source/>Nucleic Acids Res.<year>2010</year>; <volume>38</volume>:<fpage>4120</fpage>–<lpage>4132</lpage>.<pub-id pub-id-type="pmid">20194115</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kozbial</surname><given-names>P.Z.</given-names></name>, <name name-style="western"><surname>Mushegian</surname><given-names>A.R.</given-names></name></person-group>
<article-title>Natural history of S-adenosylmethionine-binding proteins</article-title>. <source/>BMC Struct. Biol.<year>2005</year>; <volume>5</volume>:<fpage>19</fpage>.<pub-id pub-id-type="pmid">16225687</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Goto-Ito</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yokoyama</surname><given-names>S.</given-names></name></person-group>
<article-title>Trm5 and trmd: two enzymes from distinct origins catalyze the identical tRNA modification, m1g37</article-title>. <source/>Biomolecules. <year>2017</year>; <volume>7</volume>:<fpage>32</fpage>.</mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Torres</surname><given-names>A.G.</given-names></name>, <name name-style="western"><surname>Batlle</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ribas de Pouplana</surname><given-names>L.</given-names></name></person-group>
<article-title>Role of tRNA modifications in human diseases</article-title>. <source/>Trends Mol. Med.<year>2014</year>; <volume>20</volume>:<fpage>306</fpage>–<lpage>314</lpage>.<pub-id pub-id-type="pmid">24581449</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Edvardson</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Prunetti</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Arraf</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Haas</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Bacusmo</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Ta-Shma</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dedon</surname><given-names>P.C.</given-names></name>, <name name-style="western"><surname>de Crécy-Lagard</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Elpeleg</surname><given-names>O.</given-names></name></person-group>
<article-title>tRNA N6-adenosine threonylcarbamoyltransferase defect due to KAE1/TCS3 (OSGEP) mutation manifest by neurodegeneration and renal tubulopathy</article-title>. <source/>Eur. J. Hum. Genet.<year>2017</year>; <volume>25</volume>:<fpage>545</fpage>–<lpage>551</lpage>.<pub-id pub-id-type="pmid">28272532</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bednářová</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hanna</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Durham</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>VanCleave</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>England</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Chaudhuri</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Krishnan</surname><given-names>N.</given-names></name></person-group>
<article-title>Lost in translation: defects in transfer RNA modifications and neurological disorders</article-title>. <source/>Front. Mol. Neurosci.<year>2017</year>; <volume>10</volume>:<fpage>135</fpage>.<pub-id pub-id-type="pmid">28536502</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sarin</surname><given-names>L.P.</given-names></name>, <name name-style="western"><surname>Leidel</surname><given-names>S.A.</given-names></name></person-group>
<article-title>Modify or die? - RNA modification defects in metazoans</article-title>. <source/>RNA Biol.<year>2014</year>; <volume>11</volume>:<fpage>1555</fpage>–<lpage>1567</lpage>.<pub-id pub-id-type="pmid">25692999</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jonkhout</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Tran</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Schonrock</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Mattick</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Novoa</surname><given-names>E.M.</given-names></name></person-group>
<article-title>The RNA modification landscape in human disease</article-title>. <source/>RNA. <year>2017</year>; <volume>23</volume>:<fpage>1754</fpage>–<lpage>1769</lpage>.<pub-id pub-id-type="pmid">28855326</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pereira</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Francisco</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Varanda</surname><given-names>A.S.</given-names></name>, <name name-style="western"><surname>Santos</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Santos</surname><given-names>M.A.S.</given-names></name>, <name name-style="western"><surname>Soares</surname><given-names>A.R.</given-names></name></person-group>
<article-title>Impact of tRNA modifications and tRNA-modifying enzymes on proteostasis and human disease</article-title>. <source/>Int. J. Mol. Sci.<year>2018</year>; <volume>19</volume>:<fpage>3738</fpage>.</mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name></person-group>
<article-title>A complete landscape of post-transcriptional modifications in mammalian mitochondrial tRNAs</article-title>. <source/>Nucleic Acids Res.<year>2014</year>; <volume>42</volume>:<fpage>7346</fpage>–<lpage>7357</lpage>.<pub-id pub-id-type="pmid">24831542</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bohnsack</surname><given-names>M.T.</given-names></name>, <name name-style="western"><surname>Sloan</surname><given-names>K.E.</given-names></name></person-group>
<article-title>The mitochondrial epitranscriptome: the roles of RNA modifications in mitochondrial translation and human disease</article-title>. <source/>Cell. Mol. Life Sci.<year>2018</year>; <volume>75</volume>:<fpage>241</fpage>–<lpage>260</lpage>.<pub-id pub-id-type="pmid">28752201</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Towns</surname><given-names>W.L.</given-names></name>, <name name-style="western"><surname>Begley</surname><given-names>T.J.</given-names></name></person-group>
<article-title>Transfer RNA Methytransferases and their corresponding modifications in budding yeast and humans: activities, predications, and potential roles in human health</article-title>. <source/>DNA Cell Biol.<year>2012</year>; <volume>31</volume>:<fpage>434</fpage>–<lpage>454</lpage>.<pub-id pub-id-type="pmid">22191691</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Maraia</surname><given-names>R.J.</given-names></name>, <name name-style="western"><surname>Arimbasseri</surname><given-names>A.G.</given-names></name></person-group>
<article-title>Factors that shape eukaryotic tRNAomes: Processing, modification and anticodon-codon use</article-title>. <source/>Biomolecules. <year>2017</year>; <volume>7</volume>:<fpage>26</fpage>.</mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Popis</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Blanco</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Frye</surname><given-names>M.</given-names></name></person-group>
<article-title>Posttranscriptional methylation of transfer and ribosomal RNA in stress response pathways, cell differentiation, and cancer</article-title>. <source/>Curr. Opin. Oncol.<year>2016</year>; <volume>28</volume>:<fpage>65</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">26599292</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Spenkuch</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Motorin</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Helm</surname><given-names>M.</given-names></name></person-group>
<article-title>Pseudouridine: still mysterious, but never a fake (uridine)</article-title>. <source/>RNA Biol.<year>2014</year>; <volume>11</volume>:<fpage>1540</fpage>–<lpage>1554</lpage>.<pub-id pub-id-type="pmid">25616362</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>P.P.</given-names></name>, <name name-style="western"><surname>Lowe</surname><given-names>T.M.</given-names></name></person-group>
<article-title>GtRNAdb 2.0: an expanded database of transfer RNA genes identified in complete and draft genomes</article-title>. <source/>Nucleic Acids Res.<year>2016</year>; <volume>44</volume>:<fpage>D184</fpage>–<lpage>D189</lpage>.<pub-id pub-id-type="pmid">26673694</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>W.C.</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Dominissini</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>T.</given-names></name></person-group>
<article-title>tRNA base methylation identification and quantification via high-throughput sequencing</article-title>. <source/>RNA. <year>2016</year>; <volume>22</volume>:<fpage>1771</fpage>–<lpage>1784</lpage>.<pub-id pub-id-type="pmid">27613580</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>W.C.</given-names></name>, <name name-style="western"><surname>Dai</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Lambowitz</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>T.</given-names></name></person-group>
<article-title>Efficient and quantitative high-throughput tRNA sequencing</article-title>. <source/>Nat. Methods. <year>2015</year>; <volume>12</volume>:<fpage>835</fpage>–<lpage>837</lpage>.<pub-id pub-id-type="pmid">26214130</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cozen</surname><given-names>A.E.</given-names></name>, <name name-style="western"><surname>Quartley</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>A.D.</given-names></name>, <name name-style="western"><surname>Hrabeta-Robinson</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Phizicky</surname><given-names>E.M.</given-names></name>, <name name-style="western"><surname>Lowe</surname><given-names>T.M.</given-names></name></person-group>
<article-title>ARM-seq: AlkB-facilitated RNA methylation sequencing reveals a complex landscape of modified tRNA fragments</article-title>. <source/>Nat. Methods. <year>2015</year>; <volume>12</volume>:<fpage>879</fpage>–<lpage>884</lpage>.<pub-id pub-id-type="pmid">26237225</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Agarwala</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Barrett</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Beck</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Benson</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Bollin</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bolton</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Bourexis</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Brister</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Bryant</surname><given-names>S.H.</given-names></name>, <name name-style="western"><surname>Canese</surname><given-names>K.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Database resources of the National Center for Biotechnology Information</article-title>. <source/>Nucleic Acids Res.<year>2016</year>; <volume>44</volume>:<fpage>D7</fpage>–<lpage>D19</lpage>.<pub-id pub-id-type="pmid">26615191</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bateman</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>O’Donovan</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Magrane</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Apweiler</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Alpi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Antunes</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Arganiska</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bely</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Bingley</surname><given-names>M.</given-names></name><etal>et al</etal>.</person-group>
<article-title>UniProt: a hub for protein information</article-title>. <source/>Nucleic Acids Res.<year>2015</year>; <volume>43</volume>:<fpage>D204</fpage>–<lpage>D212</lpage>.<pub-id pub-id-type="pmid">25348405</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gray</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Yates</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Seal</surname><given-names>R.L.</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>M.W.</given-names></name>, <name name-style="western"><surname>Bruford</surname><given-names>E.A.</given-names></name></person-group>
<article-title>Genenames.org: the HGNC resources in 2015</article-title>. <source/>Nucleic Acids Res.<year>2015</year>; <volume>43</volume>:<fpage>D1079</fpage>–<lpage>D1085</lpage>.<pub-id pub-id-type="pmid">25361968</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chatr-Aryamontri</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Oughtred</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Boucher</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Rust</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kolas</surname><given-names>N.K.</given-names></name>, <name name-style="western"><surname>O’Donnell</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Oster</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Theesfeld</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sellam</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group>
<article-title>The BioGRID interaction database: 2017 update</article-title>. <source/>Nucleic Acids Res.<year>2017</year>; <volume>45</volume>:<fpage>D369</fpage>–<lpage>D379</lpage>.<pub-id pub-id-type="pmid">27980099</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Calvo</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Clauser</surname><given-names>K.R.</given-names></name>, <name name-style="western"><surname>Mootha</surname><given-names>V.K.</given-names></name></person-group>
<article-title>MitoCarta2.0: An updated inventory of mammalian mitochondrial proteins</article-title>. <source/>Nucleic Acids Res.<year>2016</year>; <volume>44</volume>:<fpage>D1251</fpage>–<lpage>D1257</lpage>.<pub-id pub-id-type="pmid">26450961</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Krishnan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Aure</surname><given-names>M.R.</given-names></name>, <name name-style="western"><surname>Tadych</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Corney</surname><given-names>D.C.</given-names></name>, <name name-style="western"><surname>Greene</surname><given-names>C.S.</given-names></name>, <name name-style="western"><surname>Bongo</surname><given-names>L.A.</given-names></name>, <name name-style="western"><surname>Kristensen</surname><given-names>V.N.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Targeted exploration and analysis of large cross-platform human transcriptomic compendia</article-title>. <source/>Nat. Methods. <year>2015</year>; <volume>12</volume>:<fpage>211</fpage>–<lpage>214</lpage>.<pub-id pub-id-type="pmid">25581801</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Huerta-Cepas</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Capella-Gutiérrez</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pryszcz</surname><given-names>L.P.</given-names></name>, <name name-style="western"><surname>Marcet-Houben</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gabaldón</surname><given-names>T.</given-names></name></person-group>
<article-title>PhylomeDB v4: zooming into the plurality of evolutionary histories of a genome</article-title>. <source/>Nucleic Acids Res.<year>2014</year>; <volume>42</volume>:<fpage>D897</fpage>–<lpage>D902</lpage>.<pub-id pub-id-type="pmid">24275491</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ward</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Hierarchical grouping to optimize an objective function</article-title>. <source/>J. Am. Stat. Assoc.<year>1963</year>; <volume>58</volume>:<fpage>236</fpage>–<lpage>244</lpage>.</mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>M.-S.</given-names></name>, <name name-style="western"><surname>Pinto</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Getnet</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Nirujogi</surname><given-names>R.S.</given-names></name>, <name name-style="western"><surname>Manda</surname><given-names>S.S.</given-names></name>, <name name-style="western"><surname>Chaerkady</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Madugundu</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Kelkar</surname><given-names>D.S.</given-names></name>, <name name-style="western"><surname>Isserlin</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group>
<article-title>A draft map of the human proteome</article-title>. <source/>Nature. <year>2014</year>; <volume>509</volume>:<fpage>575</fpage>–<lpage>581</lpage>.<pub-id pub-id-type="pmid">24870542</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schimmel</surname><given-names>P.</given-names></name></person-group>
<article-title>RNA Processing and Modifications: The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis</article-title>. <source/>Nat. Rev. Mol. Cell Biol.<year>2018</year>; <volume>19</volume>:<fpage>45</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="pmid">28875994</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Barski</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Chepelev</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Liko</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Cuddapah</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fleming</surname><given-names>A.B.</given-names></name>, <name name-style="western"><surname>Birch</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>White</surname><given-names>R.J.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>K.</given-names></name></person-group>
<article-title>Pol II and its associated epigenetic marks are present at Pol III-transcribed noncoding RNA genes</article-title>. <source/>Nat. Struct. Mol. Biol.<year>2010</year>; <volume>17</volume>:<fpage>629</fpage>–<lpage>634</lpage>.<pub-id pub-id-type="pmid">20418881</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Canella</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Praz</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Reina</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Cousin</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>N.</given-names></name></person-group>
<article-title>Defining the RNA polymerase III transcriptome: genome-wide localization of the RNA polymerase III transcription machinery in human cells</article-title>. <source/>Genome Res.<year>2010</year>; <volume>20</volume>:<fpage>710</fpage>–<lpage>721</lpage>.<pub-id pub-id-type="pmid">20413673</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Martinez</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Choudury</surname><given-names>S.G.</given-names></name>, <name name-style="western"><surname>Slotkin</surname><given-names>R.K.</given-names></name></person-group>
<article-title>tRNA-derived small RNAs target transposable element transcripts</article-title>. <source/>Nucleic Acids Res.<year>2017</year>; <volume>45</volume>:<fpage>5142</fpage>–<lpage>5152</lpage>.<pub-id pub-id-type="pmid">28335016</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Goodarzi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>H.C.B.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fish</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Tavazoie</surname><given-names>S.F.</given-names></name></person-group>
<article-title>Endogenous tRNA-derived fragments suppress breast cancer progression via YBX1 displacement</article-title>. <source/>Cell. <year>2015</year>; <volume>161</volume>:<fpage>790</fpage>–<lpage>802</lpage>.<pub-id pub-id-type="pmid">25957686</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kataoka</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Miyauchi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ohe</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Iida</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nojima</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Okuno</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Onogi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Usui</surname><given-names>T.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.<year>2015</year>; <volume>112</volume>:<fpage>2764</fpage>–<lpage>2769</lpage>.<pub-id pub-id-type="pmid">25675486</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Johansson</surname><given-names>M.J.O.</given-names></name>, <name name-style="western"><surname>Esberg</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Björk</surname><given-names>G.R.</given-names></name>, <name name-style="western"><surname>Byström</surname><given-names>A.S.</given-names></name></person-group>
<article-title>Eukaryotic wobble uridine modifications promote a functionally redundant decoding system</article-title>. <source/>Mol. Cell. Biol.<year>2008</year>; <volume>28</volume>:<fpage>3301</fpage>–<lpage>3312</lpage>.<pub-id pub-id-type="pmid">18332122</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Harada</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Gross</surname><given-names>H.J.</given-names></name>, <name name-style="western"><surname>Kimura</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>S.H.</given-names></name>, <name name-style="western"><surname>Nishimura</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>RajBhandary</surname><given-names>U.L.</given-names></name></person-group>
<article-title>2-Methylthio N6-(Δ2-isopentenyl) adenosine: a component of <italic>E. coli</italic> tyrosine transfer RNA</article-title>. <source/>Biochem. Biophys. Res. Commun.<year>1968</year>; <volume>33</volume>:<fpage>299</fpage>–<lpage>306</lpage>.<pub-id pub-id-type="pmid">4881052</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gehrke</surname><given-names>C.W.</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>K.C.</given-names></name>, <name name-style="western"><surname>Zumwalt</surname><given-names>R.W.</given-names></name></person-group>
<article-title>Chromatography of nucleosides</article-title>. <source/>J. Chromatogr. A. <year>1980</year>; <volume>188</volume>:<fpage>129</fpage>–<lpage>147</lpage>.</mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wagner</surname><given-names>T.M.</given-names></name>, <name name-style="western"><surname>Nair</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Guymon</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Pomerantz</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Crain</surname><given-names>P.F.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>D.R.</given-names></name>, <name name-style="western"><surname>McCloskey</surname><given-names>J.A.</given-names></name></person-group>
<article-title>A novel method for sequence placement of modified nucleotides in mixtures of transfer RNA</article-title>. <source/>Nucleic Acids Symp. Ser. (Oxf).<year>2004</year>; <volume>48</volume>:<fpage>263</fpage>–<lpage>264</lpage>.</mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Meng</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Limbach</surname><given-names>P.A.</given-names></name></person-group>
<article-title>Mass spectrometry of RNA: linking the genome to the proteome</article-title>. <source/>Brief. Funct. Genomics. <year>2006</year>; <volume>5</volume>:<fpage>87</fpage>–<lpage>95</lpage>.</mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ikeuchi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Noma</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname><given-names>Y.</given-names></name></person-group>
<article-title>Mass spectrometric identification and characterization of RNA-modifying enzymes</article-title>. <source/>Methods Enzymol.<year>2007</year>; <volume>425</volume>:<fpage>211</fpage>–<lpage>229</lpage>.<pub-id pub-id-type="pmid">17673085</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>W.M.</given-names></name>, <name name-style="western"><surname>Chionh</surname><given-names>Y.H.</given-names></name>, <name name-style="western"><surname>Hia</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kellner</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>McBee</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>C.S.</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>Y.L.J.</given-names></name>, <name name-style="western"><surname>Prestwich</surname><given-names>E.G.</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>K.S.</given-names></name><etal>et al</etal>.</person-group>
<article-title>A platform for discovery and quantification of modified ribonucleosides in RNA: application to stress-induced reprogramming of tRNA modifications</article-title>. <source/>Methods Enzymol.<year>2015</year>; <volume>560</volume>:<fpage>29</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">26253965</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ishimura</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Nagy</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Dotu</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Senju</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nishimura</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chuang</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Ackerman</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration</article-title>. <source/>Science. <year>2014</year>; <volume>345</volume>:<fpage>455</fpage>–<lpage>459</lpage>.<pub-id pub-id-type="pmid">25061210</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pavon-Eternod</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gomes</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Geslain</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Dai</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Rosner</surname><given-names>M.R.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>T.</given-names></name></person-group>
<article-title>tRNA over-expression in breast cancer and functional consequences</article-title>. <source/>Nucleic Acids Res.<year>2009</year>; <volume>37</volume>:<fpage>7268</fpage>–<lpage>7280</lpage>.<pub-id pub-id-type="pmid">19783824</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gogakos</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Garzia</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Meyer</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hafner</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tuschl</surname><given-names>T.</given-names></name></person-group>
<article-title>Characterizing expression and processing of precursor and mature human tRNAs by hydro-tRNAseq and PAR-CLIP</article-title>. <source/>Cell Rep.<year>2017</year>; <volume>20</volume>:<fpage>1463</fpage>–<lpage>1475</lpage>.<pub-id pub-id-type="pmid">28793268</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Marchand</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Ayadi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Ernst</surname><given-names>F.G.M.</given-names></name>, <name name-style="western"><surname>Hertler</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bourguignon-Igel</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Galvanin</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kotter</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Helm</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lafontaine</surname><given-names>D.L.J.</given-names></name>, <name name-style="western"><surname>Motorin</surname><given-names>Y.</given-names></name></person-group>
<article-title>AlkAniline-Seq: profiling of m7G and m3C RNA modifications at single nucleotide resolution</article-title>. <source/>Angew. Chem. Int. Ed. Engl.<year>2018</year>; <volume>57</volume>:<fpage>16785</fpage>–<lpage>16790</lpage>.<pub-id pub-id-type="pmid">30370969</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Limbach</surname><given-names>P.A.</given-names></name>, <name name-style="western"><surname>Paulines</surname><given-names>M.J.</given-names></name></person-group>
<article-title>Going global: the new era of mapping modifications in RNA</article-title>. <source/>Wiley Interdiscip. Rev. RNA. <year>2017</year>; <volume>8</volume>:<fpage>e1367</fpage>.</mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Miyauchi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ikeuchi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Thiaville</surname><given-names>P.C.</given-names></name>, <name name-style="western"><surname>de Crécy-Lagard</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name></person-group>
<article-title>Discovery of the β-barrel-type RNA methyltransferase responsible for N6-methylation of N6-threonylcarbamoyladenosine in tRNAs</article-title>. <source/>Nucleic Acids Res.<year>2014</year>; <volume>42</volume>:<fpage>9350</fpage>–<lpage>9365</lpage>.<pub-id pub-id-type="pmid">25063302</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fislage</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Roovers</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tuszynska</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Bujnicki</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Droogmans</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Versées</surname><given-names>W.</given-names></name></person-group>
<article-title>Crystal structures of the tRNA:m2G6 methyltransferase Trm14/TrmN from two domains of life</article-title>. <source/>Nucleic Acids Res.<year>2012</year>; <volume>40</volume>:<fpage>5149</fpage>–<lpage>5161</lpage>.<pub-id pub-id-type="pmid">22362751</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sergiev</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Bogdanov</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Dontsova</surname><given-names>O.A.</given-names></name></person-group>
<article-title>Ribosomal RNA guanine-(N2)-methyltransferases and their targets</article-title>. <source/>Nucleic Acids Res.<year>2007</year>; <volume>35</volume>:<fpage>2295</fpage>–<lpage>2301</lpage>.<pub-id pub-id-type="pmid">17389639</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bourgeois</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Létoquart</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>van Tran</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Graille</surname><given-names>M.</given-names></name></person-group>
<article-title>Trm112, a protein activator of methyltransferases modifying actors of the eukaryotic translational apparatus</article-title>. <source/>Biomolecules. <year>2017</year>; <volume>7</volume>:<fpage>E7</fpage>.<pub-id pub-id-type="pmid">28134793</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jackman</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Montange</surname><given-names>R.K.</given-names></name>, <name name-style="western"><surname>Malik</surname><given-names>H.S.</given-names></name>, <name name-style="western"><surname>Phizicky</surname><given-names>E.M.</given-names></name></person-group>
<article-title>Identification of the yeast gene encoding the tRNA m1G methyltransferase responsible for modification at position 9</article-title>. <source/>RNA. <year>2003</year>; <volume>9</volume>:<fpage>574</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">12702816</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Evans</surname><given-names>D.G.</given-names></name>, <name name-style="western"><surname>Harkness</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Lalloo</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Howell</surname><given-names>A.</given-names></name></person-group>
<article-title>Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies</article-title>. <source/>J. Med. Genet.<year>2014</year>; <volume>51</volume>:<fpage>573</fpage>–<lpage>580</lpage>.<pub-id pub-id-type="pmid">25053764</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Van Laer</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Roovers</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wauters</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kasprzak</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Dyzma</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Deyaert</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>R.K.</given-names></name>, <name name-style="western"><surname>Feller</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bujnicki</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Droogmans</surname><given-names>L.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Structural and functional insights into tRNA binding and adenosine N1-methylation by an archaeal Trm10 homologue</article-title>. <source/>Nucleic Acids Res.<year>2016</year>; <volume>44</volume>:<fpage>940</fpage>–<lpage>953</lpage>.<pub-id pub-id-type="pmid">26673726</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Vilardo</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Nachbagauer</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Buzet</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Taschner</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Holzmann</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rossmanith</surname><given-names>W.</given-names></name></person-group>
<article-title>A subcomplex of human mitochondrial RNase P is a bifunctional methyltransferase - extensive moonlighting in mitochondrial tRNA biogenesis</article-title>. <source/>Nucleic Acids Res.<year>2018</year>; <volume>46</volume>:<fpage>11126</fpage>–<lpage>11127</lpage>.<pub-id pub-id-type="pmid">30295808</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Armengaud</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Dedieu</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Solques</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Pellequer</surname><given-names>J.L.</given-names></name>, <name name-style="western"><surname>Quemeneur</surname><given-names>E.</given-names></name></person-group>
<article-title>Deciphering structure and topology of conserved COG2042 orphan proteins</article-title>. <source/>BMC Struct. Biol.<year>2005</year>; <volume>5</volume>:<fpage>3</fpage>.<pub-id pub-id-type="pmid">15701177</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Meyer</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Wurm</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Immer</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pogoryelov</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Kötter</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Lafontaine</surname><given-names>D.L.J.</given-names></name>, <name name-style="western"><surname>Wöhnert</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Entian</surname><given-names>K.D.</given-names></name></person-group>
<article-title>Ribosome biogenesis factor Tsr3 is the aminocarboxypropyl transferase responsible for 18S rRNA hypermodification in yeast and humans</article-title>. <source/>Nucleic Acids Res.<year>2016</year>; <volume>44</volume>:<fpage>4304</fpage>–<lpage>4316</lpage>.<pub-id pub-id-type="pmid">27084949</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Umitsu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nishimasu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Noma</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ishitani</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Nureki</surname><given-names>O.</given-names></name></person-group>
<article-title>Structural basis of AdoMet-dependent aminocarboxypropyl transfer reaction catalyzed by tRNA-wybutosine synthesizing enzyme, TYW2</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.<year>2009</year>; <volume>106</volume>:<fpage>15616</fpage>–<lpage>15621</lpage>.<pub-id pub-id-type="pmid">19717466</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schaffrath</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Abdel-Fattah</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Klassen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Stark</surname><given-names>M.J.R.</given-names></name></person-group>
<article-title>The diphthamide modification pathway from <italic>Saccharomyces cerevisiae</italic> - revisited</article-title>. <source/>Mol. Microbiol.<year>2014</year>; <volume>94</volume>:<fpage>1213</fpage>–<lpage>1226</lpage>.<pub-id pub-id-type="pmid">25352115</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zaganelli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rebelo-Guiomar</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Maundrell</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Rozanska</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pierredon</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Powell</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Jourdain</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Hulo</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Lightowlers</surname><given-names>R.N.</given-names></name>, <name name-style="western"><surname>Chrzanowska-Lightowlers</surname><given-names>Z.M.</given-names></name><etal>et al</etal>.</person-group>
<article-title>The pseudouridine synthase RPUSD4 is an essential component of mitochondrial RNA granules</article-title>. <source/>J. Biol. Chem.<year>2017</year>; <volume>292</volume>:<fpage>4519</fpage>–<lpage>4532</lpage>.<pub-id pub-id-type="pmid">28082677</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Antonicka</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Choquet</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Gingras</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kleinman</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Shoubridge</surname><given-names>E.A.</given-names></name></person-group>
<article-title>A pseudouridine synthase module is essential for mitochondrial protein synthesis and cell viability</article-title>. <source/>EMBO Rep.<year>2017</year>; <volume>18</volume>:<fpage>28</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">27974379</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kaya</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ofengand</surname><given-names>J.</given-names></name></person-group>
<article-title>A novel unanticipated type of pseudouridine synthase with homologs in bacteria, archaea, and eukarya</article-title>. <source/>RNA. <year>2003</year>; <volume>9</volume>:<fpage>711</fpage>–<lpage>721</lpage>.<pub-id pub-id-type="pmid">12756329</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Urban</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Behm-Ansmant</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Branlant</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Motorin</surname><given-names>Y.</given-names></name></person-group>
<article-title>RNA sequence and two-dimensional structure features required for efficient substrate modification by the <italic>Saccharomyces cerevisiae</italic> RNA:Ψ-synthase Pus7p</article-title>. <source/>J. Biol. Chem.<year>2009</year>; <volume>284</volume>:<fpage>5845</fpage>–<lpage>5858</lpage>.<pub-id pub-id-type="pmid">19114708</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Guzzi</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Cieśla</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ngoc</surname><given-names>P.C.T.</given-names></name>, <name name-style="western"><surname>Lang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Arora</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Dimitriou</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pimková</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Sommarin</surname><given-names>M.N.E.</given-names></name>, <name name-style="western"><surname>Munita</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Lubas</surname><given-names>M.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Pseudouridylation of tRNA-derived fragments steers translational control in stem cells</article-title>. <source/>Cell. <year>2018</year>; <volume>173</volume>:<fpage>1204</fpage>–<lpage>1216</lpage>.<pub-id pub-id-type="pmid">29628141</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Behm-Ansmant</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Massenet</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Immel</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Patton</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Motorin</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Branlant</surname><given-names>C.</given-names></name></person-group>
<article-title>A previously unidentified activity of yeast and mouse RNA: pseudouridine synthases 1 (Pus1p) on tRNAs</article-title>. <source/>RNA. <year>2006</year>; <volume>12</volume>:<fpage>1583</fpage>–<lpage>1593</lpage>.<pub-id pub-id-type="pmid">16804160</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Joardar</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jana</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fitzek</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Gurha</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Majumder</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Chatterjee</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Geisler</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>R.</given-names></name></person-group>
<article-title>Role of forefinger and thumb loops in production of Ψ54 and Ψ55 in tRNAs by archaeal Pus10</article-title>. <source/>RNA. <year>2013</year>; <volume>19</volume>:<fpage>1279</fpage>–<lpage>1294</lpage>.<pub-id pub-id-type="pmid">23898217</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Deogharia</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mukhopadhyay</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Joardar</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>R.</given-names></name></person-group>
<article-title>The human ortholog of archaeal Pus10 produces pseudouridine 54 in select tRNAs where its recognition sequence contains a modified residue</article-title>. <source/>RNA. <year>2018</year>; <comment>doi:10.1261/rna.068114.118</comment>.</mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fergus</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Barnes</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Alqasem</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>V.P.</given-names></name></person-group>
<article-title>The queuine micronutrient: charting a course from microbe to man</article-title>. <source/>Nutrients. <year>2015</year>; <volume>7</volume>:<fpage>2897</fpage>–<lpage>2929</lpage>.<pub-id pub-id-type="pmid">25884661</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tuorto</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Legrand</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Cirzi</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Federico</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Liebers</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Müller</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ehrenhofer-Murray</surname><given-names>A.E.</given-names></name>, <name name-style="western"><surname>Dittmar</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Gröne</surname><given-names>H.-J.</given-names></name>, <name name-style="western"><surname>Lyko</surname><given-names>F.</given-names></name></person-group>
<article-title>Queuosine-modified tRNAs confer nutritional control of protein translation</article-title>. <source/>EMBO J.<year>2018</year>; <volume>37</volume>:<fpage>e99777</fpage>.<pub-id pub-id-type="pmid">30093495</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zallot</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Brochier-Armanet</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Gaston</surname><given-names>K.W.</given-names></name>, <name name-style="western"><surname>Forouhar</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Limbach</surname><given-names>P.A.</given-names></name>, <name name-style="western"><surname>Hunt</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>de Crécy-Lagard</surname><given-names>V.</given-names></name></person-group>
<article-title>Plant, animal, and fungal micronutrient queuosine is salvaged by members of the DUF2419 protein family</article-title>. <source/>ACS Chem. Biol.<year>2014</year>; <volume>9</volume>:<fpage>1812</fpage>–<lpage>1825</lpage>.<pub-id pub-id-type="pmid">24911101</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schaffrath</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Leidel</surname><given-names>S.A.</given-names></name></person-group>
<article-title>Wobble uridine modifications–a reason to live, a reason to die?</article-title>. <source/>RNA Biol.<year>2017</year>; <volume>14</volume>:<fpage>1209</fpage>–<lpage>1222</lpage>.<pub-id pub-id-type="pmid">28277930</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Grosjean</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Westhof</surname><given-names>E.</given-names></name></person-group>
<article-title>An integrated, structure- and energy-based view of the genetic code</article-title>. <source/>Nucleic Acids Res.<year>2016</year>; <volume>44</volume>:<fpage>8020</fpage>–<lpage>8040</lpage>.<pub-id pub-id-type="pmid">27448410</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dauden</surname><given-names>M.I.</given-names></name>, <name name-style="western"><surname>Jaciuk</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Müller</surname><given-names>C.W.</given-names></name>, <name name-style="western"><surname>Glatt</surname><given-names>S.</given-names></name></person-group>
<article-title>Structural asymmetry in the eukaryotic Elongator complex</article-title>. <source/>FEBS Lett.<year>2018</year>; <volume>592</volume>:<fpage>502</fpage>–<lpage>515</lpage>.<pub-id pub-id-type="pmid">28960290</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Brophy</surname><given-names>J.A.N.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>C.T.Y.</given-names></name>, <name name-style="western"><surname>Atmore</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Begley</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Paules</surname><given-names>R.S.</given-names></name>, <name name-style="western"><surname>Dedon</surname><given-names>P.C.</given-names></name>, <name name-style="western"><surname>Begley</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Samson</surname><given-names>L.D.</given-names></name></person-group>
<article-title>Human AlkB homolog ABH8 Is a tRNA methyltransferase required for wobble uridine modification and DNA damage survival</article-title>. <source/>Mol. Cell. Biol.<year>2010</year>; <volume>30</volume>:<fpage>2449</fpage>–<lpage>2459</lpage>.<pub-id pub-id-type="pmid">20308323</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Dai</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>C.</given-names></name></person-group>
<article-title>The AlkB domain of mammalian ABH8 catalyzes hydroxylation of 5-methoxycarbonylmethyluridine at the wobble position of tRNA</article-title>. <source/>Angew. Chem. Int. Ed. Engl.<year>2010</year>; <volume>49</volume>:<fpage>8885</fpage>–<lpage>8888</lpage>.<pub-id pub-id-type="pmid">20583019</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Songe-Møller</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>van den Born</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Leihne</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Vågbø</surname><given-names>C.B.</given-names></name>, <name name-style="western"><surname>Kristoffersen</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Krokan</surname><given-names>H.E.</given-names></name>, <name name-style="western"><surname>Kirpekar</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Falnes</surname><given-names>P.Ø.</given-names></name>, <name name-style="western"><surname>Klungland</surname><given-names>A.</given-names></name></person-group>
<article-title>Mammalian ALKBH8 possesses tRNA methyltransferase activity required for the biogenesis of multiple wobble uridine modifications implicated in translational decoding</article-title>. <source/>Mol. Cell. Biol.<year>2010</year>; <volume>30</volume>:<fpage>1814</fpage>–<lpage>1827</lpage>.<pub-id pub-id-type="pmid">20123966</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Termathe</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Leidel</surname><given-names>S.A.</given-names></name></person-group>
<article-title>The Uba4 domain interplay is mediated via a thioester that is critical for tRNA thiolation through Urm1 thiocarboxylation</article-title>. <source/>Nucleic Acids Res.<year>2018</year>; <volume>46</volume>:<fpage>5171</fpage>–<lpage>5181</lpage>.<pub-id pub-id-type="pmid">29718331</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chowdhury</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Dosche</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Löhmannsröben</surname><given-names>H.-G.</given-names></name>, <name name-style="western"><surname>Leimkühler</surname><given-names>S.</given-names></name></person-group>
<article-title>Dual role of the molybdenum cofactor biosynthesis protein MOCS3 in tRNA thiolation and molybdenum cofactor biosynthesis in humans</article-title>. <source/>J. Biol. Chem.<year>2012</year>; <volume>287</volume>:<fpage>17297</fpage>–<lpage>17307</lpage>.<pub-id pub-id-type="pmid">22453920</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bujnicki</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Feder</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ayres</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Redman</surname><given-names>K.L.</given-names></name></person-group>
<article-title>Sequence-structure-function studies of tRNA:m5C methyltransferase Trm4p and its relationship to DNA:m5C and RNA:m5U methyltransferases</article-title>. <source/>Nucleic Acids Res.<year>2004</year>; <volume>32</volume>:<fpage>2453</fpage>–<lpage>2463</lpage>.<pub-id pub-id-type="pmid">15121902</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Auxilien</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Guérineau</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Szweykowska-Kuliñska</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Golinelli-Pimpaneau</surname><given-names>B.</given-names></name></person-group>
<article-title>The human tRNA m5C methyltransferase Misu is multisite-specific</article-title>. <source/>RNA Biol.<year>2012</year>; <volume>9</volume>:<fpage>1331</fpage>–<lpage>1338</lpage>.<pub-id pub-id-type="pmid">22995836</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Aguilo</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S. De</given-names></name>, <name name-style="western"><surname>Balasubramaniyan</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Sancho</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Benko</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Vashisht</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Rengasamy</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Andino</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C. hung</given-names></name><etal>et al</etal>.</person-group>
<article-title>Deposition of 5-methylcytosine on enhancer RNAs enables the coactivator function of PGC-1α</article-title>. <source/>Cell Rep.<year>2016</year>; <volume>14</volume>:<fpage>479</fpage>–<lpage>492</lpage>.<pub-id pub-id-type="pmid">26774474</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Sheng</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Oo</surname><given-names>K.S.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chionh</surname><given-names>Y.H.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y.-G.</given-names></name>, <name name-style="western"><surname>Dedon</surname><given-names>P.C.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Three distinct 3-methylcytidine (m3C) methyltransferases modify tRNA and mRNA in mice and humans</article-title>. <source/>J. Biol. Chem.<year>2017</year>; <volume>292</volume>:<fpage>14695</fpage>–<lpage>14703</lpage>.<pub-id pub-id-type="pmid">28655767</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kawarada</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ohira</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Miyauchi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name></person-group>
<article-title>ALKBH1 is an RNA dioxygenase responsible for cytoplasmic and mitochondrial tRNA modifications</article-title>. <source/>Nucleic Acids Res.<year>2017</year>; <volume>45</volume>:<fpage>7401</fpage>–<lpage>7415</lpage>.<pub-id pub-id-type="pmid">28472312</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Haag</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sloan</surname><given-names>K.E.</given-names></name>, <name name-style="western"><surname>Ranjan</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Warda</surname><given-names>A.S.</given-names></name>, <name name-style="western"><surname>Kretschmer</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Blessing</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hübner</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Seikowski</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Dennerlein</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rehling</surname><given-names>P.</given-names></name><etal>et al</etal>.</person-group>
<article-title>NSUN3 and ABH1 modify the wobble position of mt‐tRNA <sup>Met</sup> to expand codon recognition in mitochondrial translation</article-title>. <source/>EMBO J.<year>2016</year>; <volume>35</volume>:<fpage>2104</fpage>–<lpage>2119</lpage>.<pub-id pub-id-type="pmid">27497299</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Van Haute</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Dietmann</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kremer</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hussain</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pearce</surname><given-names>S.F.</given-names></name>, <name name-style="western"><surname>Powell</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Rorbach</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lantaff</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Blanco</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sauer</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Deficient methylation and formylation of mt-tRNAMetwobble cytosine in a patient carrying mutations in NSUN3</article-title>. <source/>Nat. Commun.<year>2016</year>; <volume>7</volume>:<fpage>12039</fpage>.<pub-id pub-id-type="pmid">27356879</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y.C.</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>V.P.</given-names></name>, <name name-style="western"><surname>Stachura</surname><given-names>S. V.</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>G.A.</given-names></name></person-group>
<article-title>Characterization of the human tRNA-guanine transglycosylase: confirmation of the heterodimeric subunit structure</article-title>. <source/>RNA. <year>2010</year>; <volume>16</volume>:<fpage>958</fpage>–<lpage>968</lpage>.<pub-id pub-id-type="pmid">20354154</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Boland</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hayes</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Santa-Maria</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Nishimura</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>V.P.</given-names></name></person-group>
<article-title>Queuosine formation in eukaryotic tRNA occurs via a mitochondria-localized heteromeric transglycosylase</article-title>. <source/>J. Biol. Chem.<year>2009</year>; <volume>284</volume>:<fpage>18218</fpage>–<lpage>18227</lpage>.<pub-id pub-id-type="pmid">19414587</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jana</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>A.C.</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>R.</given-names></name></person-group>
<article-title>Reciprocal amplification of caspase-3 activity by nuclear export of a putative human RNA-modifying protein, PUS10 during TRAIL-induced apoptosis</article-title>. <source/>Cell Death Dis.<year>2017</year>; <volume>8</volume>:<fpage>e3093</fpage>.<pub-id pub-id-type="pmid">28981101</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>F.Y.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Miyata</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ujihara</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Horiguchi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Michiue</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Fujimura</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Cdk5rap1-mediated 2-methylthio modification of mitochondrial tRNAs governs protein translation and contributes to myopathy in mice and humans</article-title>. <source/>Cell Metab.<year>2015</year>; <volume>21</volume>:<fpage>428</fpage>–<lpage>442</lpage>.<pub-id pub-id-type="pmid">25738458</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fakruddin</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>F.Y.</given-names></name>, <name name-style="western"><surname>Emura</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Matsuda</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yasukawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Tomizawa</surname><given-names>K.</given-names></name></person-group>
<article-title>Cdk5rap1-mediated 2-methylthio-N6-isopentenyladenosine modification is absent from nuclear-derived RNA species</article-title>. <source/>Nucleic Acids Res.<year>2017</year>; <volume>45</volume>:<fpage>11954</fpage>–<lpage>11961</lpage>.<pub-id pub-id-type="pmid">28981754</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Thiaville</surname><given-names>P.C.</given-names></name>, <name name-style="western"><surname>Iwata-Reuyl</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>DeCrécy-Lagard</surname><given-names>V.</given-names></name></person-group>
<article-title>Diversity of the biosynthesis pathway for threonylcarbamoyladenosine (t6A), a universal modification of tRNA</article-title>. <source/>RNA Biol.<year>2014</year>; <volume>11</volume>:<fpage>1529</fpage>–<lpage>1539</lpage>.<pub-id pub-id-type="pmid">25629598</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Thiaville</surname><given-names>P.C.</given-names></name>, <name name-style="western"><surname>Yacoubi</surname><given-names>B. El</given-names></name>, <name name-style="western"><surname>Perrochia</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hecker</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Prigent</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Thiaville</surname><given-names>J.J.</given-names></name>, <name name-style="western"><surname>Forterre</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Namy</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Basta</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>de Crécy-Lagard</surname><given-names>V.</given-names></name></person-group>
<article-title>Cross kingdom functional conservation of the core universally conserved threonylcarbamoyladenosine tRNA synthesis enzymes</article-title>. <source/>Eukaryot. Cell. <year>2014</year>; <volume>13</volume>:<fpage>1222</fpage>–<lpage>1231</lpage>.<pub-id pub-id-type="pmid">25038083</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kramer</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Graham</surname><given-names>D.E.</given-names></name>, <name name-style="western"><surname>Appling</surname><given-names>D.R.</given-names></name></person-group>
<article-title>Yeast mitochondrial initiator tRNA is methylated at guanosine 37 by the Trm5-encoded tRNA (guanine-N1-)-methyltransferase</article-title>. <source/>J. Biol. Chem.<year>2007</year>; <volume>282</volume>:<fpage>27744</fpage>–<lpage>27753</lpage>.<pub-id pub-id-type="pmid">17652090</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Leidel</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pedrioli</surname><given-names>P.G.A.</given-names></name>, <name name-style="western"><surname>Bucher</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Brost</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Costanzo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Aebersold</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Boone</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hofmann</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Peter</surname><given-names>M.</given-names></name></person-group>
<article-title>Ubiquitin-related modifier Urm1 acts as a sulphur carrier in thiolation of eukaryotic transfer RNA</article-title>. <source/>Nature. <year>2009</year>; <volume>458</volume>:<fpage>228</fpage>–<lpage>232</lpage>.<pub-id pub-id-type="pmid">19145231</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Waller</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Read</surname><given-names>D.F.</given-names></name>, <name name-style="western"><surname>Engelke</surname><given-names>D.R.</given-names></name>, <name name-style="western"><surname>Smaldino</surname><given-names>P.J.</given-names></name></person-group>
<article-title>The human tRNA-modifying protein, TRIT1, forms amyloid fibers in vitro</article-title>. <source/>Gene. <year>2017</year>; <volume>612</volume>:<fpage>19</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">27984194</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pratt-Hyatt</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pai</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Haeusler</surname><given-names>R.A.</given-names></name>, <name name-style="western"><surname>Wozniak</surname><given-names>G.G.</given-names></name>, <name name-style="western"><surname>Good</surname><given-names>P.D.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>E.L.</given-names></name>, <name name-style="western"><surname>McLeod</surname><given-names>I.X.</given-names></name>, <name name-style="western"><surname>Yates</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Hopper</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Engelke</surname><given-names>D.R.</given-names></name></person-group>
<article-title>Mod5 protein binds to tRNA gene complexes and affects local transcriptional silencing</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.<year>2013</year>; <volume>110</volume>:<fpage>E3081</fpage>–<lpage>E3089</lpage>.<pub-id pub-id-type="pmid">23898186</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Keffer-Wilkes</surname><given-names>L.C.</given-names></name>, <name name-style="western"><surname>Veerareddygari</surname><given-names>G.R.</given-names></name>, <name name-style="western"><surname>Kothe</surname><given-names>U.</given-names></name></person-group>
<article-title>RNA modification enzyme TruB is a tRNA chaperone</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.<year>2016</year>; <volume>113</volume>:<fpage>14306</fpage>–<lpage>14311</lpage>.<pub-id pub-id-type="pmid">27849601</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Docherty</surname><given-names>N.G.</given-names></name>, <name name-style="western"><surname>Griffin</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Howlin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>McArdle</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>McMahon</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Schmid</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kretzler</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Droguett</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Mezzano</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group>
<article-title>IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosis</article-title>. <source/>J. Am. Soc. Nephrol.<year>2008</year>; <volume>19</volume>:<fpage>1672</fpage>–<lpage>1680</lpage>.<pub-id pub-id-type="pmid">18508967</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cosentino</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Toivonen</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Diaz Villamil</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Atta</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ravanat</surname><given-names>J.-L.</given-names></name>, <name name-style="western"><surname>Demine</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schiavo</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Pachera</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Deglasse</surname><given-names>J.-P.</given-names></name>, <name name-style="western"><surname>Jonas</surname><given-names>J.-C.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Pancreatic β-cell tRNA hypomethylation and fragmentation link TRMT10A deficiency with diabetes</article-title>. <source/>Nucleic Acids Res.<year>2018</year>; <volume>46</volume>:<fpage>10302</fpage>–<lpage>10318</lpage>.<pub-id pub-id-type="pmid">30247717</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.-L.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H.-J.</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>X.-Y.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>X.-Z.</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>Y.-X.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>McNutt</surname><given-names>M.A.</given-names></name><etal>et al</etal>.</person-group>
<article-title>GSK-3β-regulated N-acetyltransferase 10 is involved in colorectal cancer invasion</article-title>. <source/>Clin. Cancer Res.<year>2014</year>; <volume>20</volume>:<fpage>4717</fpage>–<lpage>4729</lpage>.<pub-id pub-id-type="pmid">24982245</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Miao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name></person-group>
<article-title>Cytosolic THUMPD1 promotes breast cancer cells invasion and metastasis via the AKT-GSK3-Snail pathway</article-title>. <source/>Oncotarget. <year>2017</year>; <volume>8</volume>:<fpage>13357</fpage>–<lpage>13366</lpage>.<pub-id pub-id-type="pmid">28076326</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name></person-group>
<article-title>Expression of TARBP1 protein in human non-small-cell lung cancer and its prognostic significance</article-title>. <source/>Oncol. Lett.<year>2018</year>; <volume>15</volume>:<fpage>7182</fpage>–<lpage>7190</lpage>.<pub-id pub-id-type="pmid">29731880</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sand</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Skrygan</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Georgas</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Arenz</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Gambichler</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sand</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Altmeyer</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Bechara</surname><given-names>F.G.</given-names></name></person-group>
<article-title>Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer</article-title>. <source/>Mol. Carcinog.<year>2012</year>; <volume>51</volume>:<fpage>916</fpage>–<lpage>922</lpage>.<pub-id pub-id-type="pmid">22025453</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kato</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Daigo</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Hayama</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ishikawa</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Yamabuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Miyamoto</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kondo</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>Y.</given-names></name></person-group>
<article-title>A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis</article-title>. <source/>Cancer Res.<year>2005</year>; <volume>65</volume>:<fpage>5638</fpage>–<lpage>5646</lpage>.<pub-id pub-id-type="pmid">15994936</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bykhovskaya</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Casas</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Mengesha</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Inbal</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fischel-Ghodsian</surname><given-names>N.</given-names></name></person-group>
<article-title>Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA)</article-title>. <source/>Am. J. Hum. Genet.<year>2004</year>; <volume>74</volume>:<fpage>1303</fpage>–<lpage>1308</lpage>.<pub-id pub-id-type="pmid">15108122</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gatza</surname><given-names>M.L.</given-names></name>, <name name-style="western"><surname>Silva</surname><given-names>G.O.</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Perou</surname><given-names>C.M.</given-names></name></person-group>
<article-title>An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer</article-title>. <source/>Nat. Genet.<year>2014</year>; <volume>46</volume>:<fpage>1051</fpage>–<lpage>1059</lpage>.<pub-id pub-id-type="pmid">25151356</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>X.-L.</given-names></name>, <name name-style="western"><surname>Moyer</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Fridley</surname><given-names>B.L.</given-names></name>, <name name-style="western"><surname>Schaid</surname><given-names>D.J.</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Batzler</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Jenkins</surname><given-names>G.D.</given-names></name>, <name name-style="western"><surname>Abo</surname><given-names>R.P.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Cunningham</surname><given-names>J.M.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy</article-title>. <source/>Clin. Cancer Res.<year>2011</year>; <volume>17</volume>:<fpage>5801</fpage>–<lpage>5811</lpage>.<pub-id pub-id-type="pmid">21775533</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Alazami</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Hijazi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Al-Dosari</surname><given-names>M.S.</given-names></name>, <name name-style="western"><surname>Shaheen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hashem</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Aldahmesh</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Mohamed</surname><given-names>J.Y.</given-names></name>, <name name-style="western"><surname>Kentab</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Salih</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Awaji</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mutation in ADAT3, encoding adenosine deaminase acting on transfer RNA, causes intellectual disability and strabismus</article-title>. <source/>J. Med. Genet.<year>2013</year>; <volume>50</volume>:<fpage>425</fpage>–<lpage>430</lpage>.<pub-id pub-id-type="pmid">23620220</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Frye</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Watt</surname><given-names>F.M.</given-names></name></person-group>
<article-title>The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors</article-title>. <source/>Curr. Biol.<year>2006</year>; <volume>16</volume>:<fpage>971</fpage>–<lpage>981</lpage>.<pub-id pub-id-type="pmid">16713953</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Guy</surname><given-names>M.P.</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Weiner</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Hobson</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Stark</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kalscheuer</surname><given-names>V.M.</given-names></name>, <name name-style="western"><surname>Gecz</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Phizicky</surname><given-names>E.M.</given-names></name></person-group>
<article-title>Defects in tRNA anticodon loop 2′-O-methylation are implicated in nonsyndromic X-linked intellectual disability due to mutations in FTSJ1</article-title>. <source/>Hum. Mutat.<year>2015</year>; <volume>36</volume>:<fpage>1176</fpage>–<lpage>1187</lpage>.<pub-id pub-id-type="pmid">26310293</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Lei</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Jing</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>C.</given-names></name></person-group>
<article-title>Application of chromosome microarray analysis in patients with unexplained developmental delay/intellectual disability in South China</article-title>. <source/>Pediatr. Neonatol.<year>2018</year>; <volume>S1875-9572</volume>:<fpage>30317</fpage>–<lpage>30320</lpage>.</mixed-citation>
</ref>
<ref id="B124">
<label>124.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name></person-group>
<article-title>Association of LKB1 with a WD-repeat protein WDR6 is implicated in cell growth arrest and p27(Kip1) induction</article-title>. <source/>Mol. Cell. Biochem.<year>2007</year>; <volume>301</volume>:<fpage>115</fpage>–<lpage>122</lpage>.<pub-id pub-id-type="pmid">17216128</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gündüz</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Elliott</surname><given-names>M.S.</given-names></name>, <name name-style="western"><surname>Seubert</surname><given-names>P.H.</given-names></name>, <name name-style="western"><surname>Houghton</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Houghton</surname><given-names>P.J.</given-names></name>, <name name-style="western"><surname>Trewyn</surname><given-names>R.W.</given-names></name>, <name name-style="western"><surname>Katze</surname><given-names>J.R.</given-names></name></person-group>
<article-title>Absence of tRNA-guanine transglycosylase in a human colon adenocarcinoma cell line</article-title>. <source/>Biochim. Biophys. Acta. <year>1992</year>; <volume>1139</volume>:<fpage>229</fpage>–<lpage>238</lpage>.<pub-id pub-id-type="pmid">1378304</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Slaugenhaupt</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Blumenfeld</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gill</surname><given-names>S.P.</given-names></name>, <name name-style="western"><surname>Leyne</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mull</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cuajungco</surname><given-names>M.P.</given-names></name>, <name name-style="western"><surname>Liebert</surname><given-names>C.B.</given-names></name>, <name name-style="western"><surname>Chadwick</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Idelson</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Reznik</surname><given-names>L.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia</article-title>. <source/>Am. J. Hum. Genet.<year>2001</year>; <volume>68</volume>:<fpage>598</fpage>–<lpage>605</lpage>.<pub-id pub-id-type="pmid">11179008</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rapino</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Delaunay</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rambow</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Tharun</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>De Tullio</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Sin</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Shostak</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Schmitz</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Piepers</surname><given-names>J.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Codon-specific translation reprogramming promotes resistance to targeted therapy</article-title>. <source/>Nature. <year>2018</year>; <volume>558</volume>:<fpage>605</fpage>–<lpage>609</lpage>.<pub-id pub-id-type="pmid">29925953</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Addis</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Ahn</surname><given-names>J.W.</given-names></name>, <name name-style="western"><surname>Dobson</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Dixit</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ogilvie</surname><given-names>C.M.</given-names></name>, <name name-style="western"><surname>Pinto</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Vaags</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Coon</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Chaste</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Microdeletions of ELP4 are associated with language impairment, autism spectrum disorder, and mental retardation</article-title>. <source/>Hum. Mutat.<year>2015</year>; <volume>36</volume>:<fpage>842</fpage>–<lpage>850</lpage>.<pub-id pub-id-type="pmid">26010655</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fadason</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ekblad</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ingram</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Schierding</surname><given-names>W.S.</given-names></name>, <name name-style="western"><surname>O’Sullivan</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Physical interactions and expression quantitative traits loci identify regulatory connections for obesity and type 2 diabetes associated SNPs</article-title>. <source/>Front. Genet.<year>2017</year>; <volume>8</volume>:<fpage>150</fpage>.<pub-id pub-id-type="pmid">29081791</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Delaunay</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rapino</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Tharun</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Heukamp</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Termathe</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Shostak</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Klevernic</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Florin</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Desmecht</surname><given-names>H.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer</article-title>. <source/>J. Exp. Med.<year>2016</year>; <volume>213</volume>:<fpage>2503</fpage>–<lpage>2523</lpage>.<pub-id pub-id-type="pmid">27811057</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zinshteyn</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>W.V.</given-names></name></person-group>
<article-title>Loss of a conserved tRNA anticodon modification perturbs cellular signaling</article-title>. <source/>PLoS Genet.<year>2013</year>; <volume>9</volume>:<fpage>e1003675</fpage>.<pub-id pub-id-type="pmid">23935536</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shaheen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Shamseldin</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Alzahrani</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Al-Yamany</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>ALMoisheer</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ewida</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Anazi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Alnemer</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Elsheikh</surname><given-names>M.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Accelerating matchmaking of novel dysmorphology syndromes through clinical and genomic characterization of a large cohort</article-title>. <source/>Genet. Med.<year>2016</year>; <volume>18</volume>:<fpage>686</fpage>–<lpage>695</lpage>.<pub-id pub-id-type="pmid">26633546</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shaheen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Al-Salam</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>El-Hattab</surname><given-names>A.W.</given-names></name>, <name name-style="western"><surname>Alkuraya</surname><given-names>F.S.</given-names></name></person-group>
<article-title>The syndrome dysmorphic facies, renal agenesis, ambiguous genitalia, microcephaly, polydactyly and lissencephaly (DREAM-PL): Report of two additional patients</article-title>. <source/>Am. J. Med. Genet. A. <year>2016</year>; <volume>170</volume>:<fpage>3222</fpage>–<lpage>3226</lpage>.<pub-id pub-id-type="pmid">27480277</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yasukochi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Oguri</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Horibe</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Fujimaki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Takeuchi</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Sakuma</surname><given-names>J.</given-names></name></person-group>
<article-title>Identification of 26 novel loci that confer susceptibility to early-onset coronary artery disease in a Japanese population</article-title>. <source/>Biomed. Rep.<year>2018</year>; <volume>9</volume>:<fpage>383</fpage>–<lpage>404</lpage>.<pub-id pub-id-type="pmid">30402224</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Powell</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Kopajtich</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>D’Souza</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>Rorbach</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kremer</surname><given-names>L.S.</given-names></name>, <name name-style="western"><surname>Husain</surname><given-names>R.A.</given-names></name>, <name name-style="western"><surname>Dallabona</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Donnini</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Alston</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Griffin</surname><given-names>H.</given-names></name><etal>et al</etal>.</person-group>
<article-title>TRMT5 mutations cause a defect in Post-transcriptional modification of mitochondrial tRNA associated with multiple Respiratory-Chain deficiencies</article-title>. <source/>Am. J. Hum. Genet.<year>2015</year>; <volume>97</volume>:<fpage>319</fpage>–<lpage>328</lpage>.<pub-id pub-id-type="pmid">26189817</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>M.-X.</given-names></name></person-group>
<article-title>A hypertension-associated mitochondrial DNA mutation introduces an m1G37 modification into tRNAMet, altering its structure and function</article-title>. <source/>J. Biol. Chem.<year>2018</year>; <volume>293</volume>:<fpage>1425</fpage>–<lpage>1438</lpage>.<pub-id pub-id-type="pmid">29222331</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rodriguez</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Elkahloun</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dutra</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pak</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Chandrasekharappa</surname><given-names>S.</given-names></name></person-group>
<article-title>Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer</article-title>. <source/>Genes. Chromosomes Cancer. <year>2007</year>; <volume>46</volume>:<fpage>694</fpage>–<lpage>707</lpage>.<pub-id pub-id-type="pmid">17440925</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Simpson</surname><given-names>H.M.</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>R.Z.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sadashivaiah</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Furusawa</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Nagaraj</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sengamalay</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Sadzewicz</surname><given-names>L.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Concurrent mutations in ATM and genes associated with common γ chain signaling in peripheral T cell lymphoma</article-title>. <source/>PLoS One. <year>2015</year>; <volume>10</volume>:<fpage>e0141906</fpage>.<pub-id pub-id-type="pmid">26536348</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yeon</surname><given-names>S.Y.</given-names></name>, <name name-style="western"><surname>Jo</surname><given-names>Y.S.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>E.J.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>M.S.</given-names></name>, <name name-style="western"><surname>Yoo</surname><given-names>N.J.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>S.H.</given-names></name></person-group>
<article-title>Frameshift mutations in repeat sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 genes in colon cancers</article-title>. <source/>Pathol. Oncol. Res.<year>2018</year>; <volume>24</volume>:<fpage>617</fpage>–<lpage>622</lpage>.<pub-id pub-id-type="pmid">28803425</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Zhai</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name></person-group>
<article-title>MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC</article-title>. <source/>Am. J. Transl. Res.<year>2016</year>; <volume>8</volume>:<fpage>4705</fpage>–<lpage>4715</lpage>.<pub-id pub-id-type="pmid">27904673</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hyun</surname><given-names>H.S.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S.H.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>H.G.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>H.S.</given-names></name>, <name name-style="western"><surname>Miyake</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Matsumoto</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Tsukaguchi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Cheong</surname><given-names>H. Il</given-names></name></person-group>
<article-title>A familial case of Galloway-Mowat syndrome due to a novel TP53RK mutation: a case report</article-title>. <source/>BMC Med. Genet.<year>2018</year>; <volume>19</volume>:<fpage>131</fpage>.<pub-id pub-id-type="pmid">30053862</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hideshima</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Cottini</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Nozawa</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Seo</surname><given-names>H.-S.</given-names></name>, <name name-style="western"><surname>Ohguchi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Samur</surname><given-names>M.K.</given-names></name>, <name name-style="western"><surname>Cirstea</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Mimura</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Iwasawa</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>P.G.</given-names></name><etal>et al</etal>.</person-group>
<article-title>p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myeloma</article-title>. <source/>Blood. <year>2017</year>; <volume>129</volume>:<fpage>1308</fpage>–<lpage>1319</lpage>.<pub-id pub-id-type="pmid">28082445</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Igoillo-Esteve</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Genin</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lambert</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Désir</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Pirson</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Abdulkarim</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Simonis</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Drielsma</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Marselli</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Marchetti</surname><given-names>P.</given-names></name><etal>et al</etal>.</person-group>
<article-title>tRNA methyltransferase homolog gene TRMT10A mutation in young onset diabetes and primary microcephaly in humans</article-title>. <source/>PLoS Genet.<year>2013</year>; <volume>9</volume>:<fpage>e1003888</fpage>.<pub-id pub-id-type="pmid">24204302</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ismail</surname><given-names>N.A.</given-names></name>, <name name-style="western"><surname>Ragab</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Abd El Dayem</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Baky</surname><given-names>A.N.A.E.</given-names></name>, <name name-style="western"><surname>Hamed</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ahmed Kamel</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Adel El Halim</surname><given-names>D.</given-names></name></person-group>
<article-title>Implication of CDKAL1 single-nucleotide polymorphism rs 9465871 in obese and non-obese Egyptian children</article-title>. <source/>Med. J. Malaysia. <year>2018</year>; <volume>73</volume>:<fpage>286</fpage>–<lpage>290</lpage>.<pub-id pub-id-type="pmid">30350806</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X.-X.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>X.-Q.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>F.-X.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y.-S.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M.</given-names></name></person-group>
<article-title>Risk-association of DNA methyltransferases polymorphisms with gastric cancer in the Southern Chinese population</article-title>. <source/>Int. J. Mol. Sci.<year>2012</year>; <volume>13</volume>:<fpage>8364</fpage>–<lpage>8378</lpage>.<pub-id pub-id-type="pmid">22942708</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chowdhury</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hobbs</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>MacLeod</surname><given-names>S.L.</given-names></name>, <name name-style="western"><surname>Cleves</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Melnyk</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>James</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Erickson</surname><given-names>S.W.</given-names></name></person-group>
<article-title>Associations between maternal genotypes and metabolites implicated in congenital heart defects</article-title>. <source/>Mol. Genet. Metab.<year>2012</year>; <volume>107</volume>:<fpage>596</fpage>–<lpage>604</lpage>.<pub-id pub-id-type="pmid">23059056</pub-id></mixed-citation>
</ref>
<ref id="B147">
<label>147.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shaheen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Faqeih</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ewida</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Alobeid</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Phizicky</surname><given-names>E.M.</given-names></name>, <name name-style="western"><surname>Alkuraya</surname><given-names>F.S.</given-names></name></person-group>
<article-title>A homozygous truncating mutation in PUS3 expands the role of tRNA modification in normal cognition</article-title>. <source/>Hum. Genet.<year>2016</year>; <volume>135</volume>:<fpage>707</fpage>–<lpage>713</lpage>.<pub-id pub-id-type="pmid">27055666</pub-id></mixed-citation>
</ref>
<ref id="B148">
<label>148.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Abdelrahman</surname><given-names>H.A.</given-names></name>, <name name-style="western"><surname>Al-Shamsi</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>B.R.</given-names></name>, <name name-style="western"><surname>Al-Gazali</surname><given-names>L.</given-names></name></person-group>
<article-title>A null variant in PUS3 confirms its involvement in intellectual disability and further delineates the associated neurodevelopmental disease</article-title>. <source/>Clin. Genet.<year>2018</year>; <volume>94</volume>:<fpage>586</fpage>–<lpage>587</lpage>.<pub-id pub-id-type="pmid">30308082</pub-id></mixed-citation>
</ref>
<ref id="B149">
<label>149.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Leschziner</surname><given-names>G.D.</given-names></name>, <name name-style="western"><surname>Coffey</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Andrew</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Gregorio</surname><given-names>S.P.</given-names></name>, <name name-style="western"><surname>Dias-Neto</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Calafato</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bentley</surname><given-names>D.R.</given-names></name>, <name name-style="western"><surname>Kinton</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Sander</surname><given-names>J.W.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>M.R.</given-names></name></person-group>
<article-title>Q8IYL2 is a candidate gene for the familial epilepsy syndrome of Partial Epilepsy with Pericentral Spikes (PEPS)</article-title>. <source/>Epilepsy Res.<year>2011</year>; <volume>96</volume>:<fpage>109</fpage>–<lpage>115</lpage>.<pub-id pub-id-type="pmid">21658913</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hadjigeorgiou</surname><given-names>G.M.</given-names></name>, <name name-style="western"><surname>Kountra</surname><given-names>P.-M.</given-names></name>, <name name-style="western"><surname>Koutsis</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Tsimourtou</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Siokas</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Dardioti</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rikos</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Marogianni</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Aloizou</surname><given-names>A.-M.</given-names></name>, <name name-style="western"><surname>Karadima</surname><given-names>G.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Replication study of GWAS risk loci in Greek multiple sclerosis patients</article-title>. <source/>Neurol. Sci.<year>2018</year>; <comment>doi:10.1007/s10072-018-3617-6</comment>.</mixed-citation>
</ref>
<ref id="B151">
<label>151.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shaheen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Abdel-Salam</surname><given-names>G.M.H.</given-names></name>, <name name-style="western"><surname>Guy</surname><given-names>M.P.</given-names></name>, <name name-style="western"><surname>Alomar</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Abdel-Hamid</surname><given-names>M.S.</given-names></name>, <name name-style="western"><surname>Afifi</surname><given-names>H.H.</given-names></name>, <name name-style="western"><surname>Ismail</surname><given-names>S.I.</given-names></name>, <name name-style="western"><surname>Emam</surname><given-names>B.A.</given-names></name>, <name name-style="western"><surname>Phizicky</surname><given-names>E.M.</given-names></name>, <name name-style="western"><surname>Alkuraya</surname><given-names>F.S.</given-names></name></person-group>
<article-title>Mutation in WDR4 impairs tRNA m(7)G46 methylation and causes a distinct form of microcephalic primordial dwarfism</article-title>. <source/>Genome Biol.<year>2015</year>; <volume>16</volume>:<fpage>210</fpage>.<pub-id pub-id-type="pmid">26416026</pub-id></mixed-citation>
</ref>
<ref id="B152">
<label>152.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hicks</surname><given-names>D.G.</given-names></name>, <name name-style="western"><surname>Janarthanan</surname><given-names>B.R.</given-names></name>, <name name-style="western"><surname>Vardarajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kulkarni</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Khoury</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Dim</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Budd</surname><given-names>G.T.</given-names></name>, <name name-style="western"><surname>Yoder</surname><given-names>B.J.</given-names></name>, <name name-style="western"><surname>Tubbs</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Schreeder</surname><given-names>M.T.</given-names></name><etal>et al</etal>.</person-group>
<article-title>The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence</article-title>. <source/>BMC Cancer. <year>2010</year>; <volume>10</volume>:<fpage>108</fpage>.<pub-id pub-id-type="pmid">20307320</pub-id></mixed-citation>
</ref>
<ref id="B153">
<label>153.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Festen</surname><given-names>E.A.M.</given-names></name>, <name name-style="western"><surname>Goyette</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Green</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Boucher</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Beauchamp</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Trynka</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Dubois</surname><given-names>P.C.</given-names></name>, <name name-style="western"><surname>Lagacé</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Stokkers</surname><given-names>P.C.F.</given-names></name>, <name name-style="western"><surname>Hommes</surname><given-names>D.W.</given-names></name><etal>et al</etal>.</person-group>
<article-title>A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease</article-title>. <source/>PLoS Genet.<year>2011</year>; <volume>7</volume>:<fpage>e1001283</fpage>.<pub-id pub-id-type="pmid">21298027</pub-id></mixed-citation>
</ref>
<ref id="B154">
<label>154.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.-M.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>D.-D.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>L.-S.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.-R.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>D.-K.</given-names></name></person-group>
<article-title>Expression and significance of m1A transmethylase, hTrm6p/hTrm61p and its related gene hTrm6/hTrm61 in bladder urothelial carcinoma</article-title>. <source/>Am. J. Cancer Res.<year>2015</year>; <volume>5</volume>:<fpage>2169</fpage>–<lpage>2179</lpage>.<pub-id pub-id-type="pmid">26328247</pub-id></mixed-citation>
</ref>
<ref id="B155">
<label>155.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Macari</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>El-Houfi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Boldina</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Khoury-Hanna</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ollier</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yazdani</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Bièche</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Legrand</surname><given-names>N.</given-names></name><etal>et al</etal>.</person-group>
<article-title>TRM6/61 connects PKCα with translational control through tRNAi(Met) stabilization: impact on tumorigenesis</article-title>. <source/>Oncogene. <year>2016</year>; <volume>35</volume>:<fpage>1785</fpage>–<lpage>1796</lpage>.<pub-id pub-id-type="pmid">26234676</pub-id></mixed-citation>
</ref>
<ref id="B156">
<label>156.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>P.K.</given-names></name><etal>et al</etal>.</person-group>
<article-title>A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis</article-title>. <source/>Nat. Cell Biol.<year>2017</year>; <volume>19</volume>:<fpage>106</fpage>–<lpage>119</lpage>.<pub-id pub-id-type="pmid">28114269</pub-id></mixed-citation>
</ref>
<ref id="B157">
<label>157.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Metodiev</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Alston</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>A.A.M.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Assouline</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Rio</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bahi-Buisson</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Pyle</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Griffin</surname><given-names>H.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Recessive mutations in TRMT10C cause defects in mitochondrial RNA processing and multiple respiratory chain deficiencies</article-title>. <source/>Am. J. Hum. Genet.<year>2016</year>; <volume>98</volume>:<fpage>993</fpage>–<lpage>1000</lpage>.<pub-id pub-id-type="pmid">27132592</pub-id></mixed-citation>
</ref>
<ref id="B158">
<label>158.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Oerum</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Roovers</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Leichsenring</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Acquaviva-Bourdain</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Beermann</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Gemperle-Britschgi</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Fouilhoux</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Korwitz-Reichelt</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>H.J.</given-names></name>, <name name-style="western"><surname>Droogmans</surname><given-names>L.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Novel patient missense mutations in the HSD17B10 gene affect dehydrogenase and mitochondrial tRNA modification functions of the encoded protein</article-title>. <source/>Biochim. Biophys. Acta Mol. Basis Dis.<year>2017</year>; <volume>1863</volume>:<fpage>3294</fpage>–<lpage>3302</lpage>.<pub-id pub-id-type="pmid">28888424</pub-id></mixed-citation>
</ref>
<ref id="B159">
<label>159.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Blaesius</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Abbasi</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Tahir</surname><given-names>T.H.</given-names></name>, <name name-style="western"><surname>Tietze</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Picker-Minh</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Farooq</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Latif</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>M.N.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mutations in the tRNA methyltransferase 1 gene TRMT1 cause congenital microcephaly, isolated inferior vermian hypoplasia and cystic leukomalacia in addition to intellectual disability</article-title>. <source/>Am. J. Med. Genet. A. <year>2018</year>; <volume>176</volume>:<fpage>2517</fpage>–<lpage>2521</lpage>.<pub-id pub-id-type="pmid">30289604</pub-id></mixed-citation>
</ref>
<ref id="B160">
<label>160.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Job</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Bernheim</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Beau-Faller</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Camilleri-Broët</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Girard</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Hofman</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Mazières</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Toujani</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lacroix</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Laffaire</surname><given-names>J.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Genomic aberrations in lung adenocarcinoma in never smokers</article-title>. <source/>PLoS One. <year>2010</year>; <volume>5</volume>:<fpage>e15145</fpage>.<pub-id pub-id-type="pmid">21151896</pub-id></mixed-citation>
</ref>
<ref id="B161">
<label>161.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>J.X.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Cloe</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yue</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Shammo</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Anastasi</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>Q.J.</given-names></name><etal>et al</etal>.</person-group>
<article-title>RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia</article-title>. <source/>Nat. Commun.<year>2018</year>; <volume>9</volume>:<fpage>1163</fpage>.<pub-id pub-id-type="pmid">29563491</pub-id></mixed-citation>
</ref>
<ref id="B162">
<label>162.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kopajtich</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Nicholls</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Rorbach</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Metodiev</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Freisinger</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Mandel</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Vanlander</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ghezzi</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Carrozzo</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>R.W.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy</article-title>. <source/>Am. J. Hum. Genet.<year>2014</year>; <volume>95</volume>:<fpage>708</fpage>–<lpage>720</lpage>.<pub-id pub-id-type="pmid">25434004</pub-id></mixed-citation>
</ref>
<ref id="B163">
<label>163.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bykhovskaya</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Mengesha</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Estivill</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Shohat</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fischel-Ghodsian</surname><given-names>N.</given-names></name></person-group>
<article-title>Phenotype of non-syndromic deafness associated with the mitochondrial A1555G mutation is modulated by mitochondrial RNA modifying enzymes MTO1 and GTPBP3</article-title>. <source/>Mol. Genet. Metab.<year>2004</year>; <volume>83</volume>:<fpage>199</fpage>–<lpage>206</lpage>.<pub-id pub-id-type="pmid">15542390</pub-id></mixed-citation>
</ref>
<ref id="B164">
<label>164.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>M.-X.</given-names></name></person-group>
<article-title>Isolation and characterization of the putative nuclear modifier gene MTO1 involved in the pathogenesis of deafness-associated mitochondrial 12 S rRNA A1555G mutation</article-title>. <source/>J. Biol. Chem.<year>2002</year>; <volume>277</volume>:<fpage>27256</fpage>–<lpage>27264</lpage>.<pub-id pub-id-type="pmid">12011058</pub-id></mixed-citation>
</ref>
<ref id="B165">
<label>165.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>R.W.</given-names></name>, <name name-style="western"><surname>Pyle</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Griffin</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Blakely</surname><given-names>E.L.</given-names></name>, <name name-style="western"><surname>Duff</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Smertenko</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Alston</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Neeve</surname><given-names>V.C.</given-names></name>, <name name-style="western"><surname>Best</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies</article-title>. <source/>JAMA. <year>2014</year>; <volume>312</volume>:<fpage>68</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">25058219</pub-id></mixed-citation>
</ref>
<ref id="B166">
<label>166.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Donner</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Katainen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kaasinen</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Aavikko</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sipilä</surname><given-names>L.J.</given-names></name>, <name name-style="western"><surname>Pukkala</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Aaltonen</surname><given-names>L.A.</given-names></name></person-group>
<article-title>Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma</article-title>. <source/>Fam. Cancer. <year>2018</year>; <comment>doi:10.1007/s10689-018-0099-x</comment>.</mixed-citation>
</ref>
<ref id="B167">
<label>167.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Miyauchi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Harada</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Okita</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Takeshita</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Komaki</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Fujioka</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yagasaki</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Goto</surname><given-names>Y.-I.</given-names></name>, <name name-style="western"><surname>Yanaka</surname><given-names>K.</given-names></name><etal>et al</etal>.</person-group>
<article-title>CO2-sensitive tRNA modification associated with human mitochondrial disease</article-title>. <source/>Nat. Commun.<year>2018</year>; <volume>9</volume>:<fpage>1875</fpage>.<pub-id pub-id-type="pmid">29760464</pub-id></mixed-citation>
</ref>
<ref id="B168">
<label>168.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kernohan</surname><given-names>K.D.</given-names></name>, <name name-style="western"><surname>Dyment</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Pupavac</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cramer</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>McBride</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bernard</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Straub</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Tetreault</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hartley</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>L.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Matchmaking facilitates the diagnosis of an autosomal-recessive mitochondrial disease caused by biallelic mutation of the tRNA isopentenyltransferase (TRIT1) gene</article-title>. <source/>Hum. Mutat.<year>2017</year>; <volume>38</volume>:<fpage>511</fpage>–<lpage>516</lpage>.<pub-id pub-id-type="pmid">28185376</pub-id></mixed-citation>
</ref>
<ref id="B169">
<label>169.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Dang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name></person-group>
<article-title>CDK5RAP1 targeting NF-κB signaling pathway in human malignant melanoma A375 cell apoptosis</article-title>. <source/>Oncol. Lett.<year>2018</year>; <volume>15</volume>:<fpage>4767</fpage>–<lpage>4774</lpage>.<pub-id pub-id-type="pmid">29552116</pub-id></mixed-citation>
</ref>
<ref id="B170">
<label>170.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Rafiq</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Noor</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hussain</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Flores</surname><given-names>J. V</given-names></name>, <name name-style="western"><surname>Rupp</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Vincent</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Malli</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>F.S.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mutation in NSUN2, which encodes an RNA methyltransferase, causes autosomal-recessive intellectual disability</article-title>. <source/>Am. J. Hum. Genet.<year>2012</year>; <volume>90</volume>:<fpage>856</fpage>–<lpage>863</lpage>.<pub-id pub-id-type="pmid">22541562</pub-id></mixed-citation>
</ref>
<ref id="B171">
<label>171.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Frye</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dragoni</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Chin</surname><given-names>S.-F.</given-names></name>, <name name-style="western"><surname>Spiteri</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Kurowski</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Provenzano</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Green</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ellis</surname><given-names>I.O.</given-names></name>, <name name-style="western"><surname>Grimmer</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Teschendorff</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer</article-title>. <source/>Cancer Lett.<year>2010</year>; <volume>289</volume>:<fpage>71</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">19740597</pub-id></mixed-citation>
</ref>
<ref id="B172">
<label>172.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Abbasi-Moheb</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Mertel</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gonsior</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nouri-Vahid</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kahrizi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Cirak</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wieczorek</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Motazacker</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Esmaeeli-Nieh</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Cremer</surname><given-names>K.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mutations in NSUN2 cause autosomal-recessive intellectual disability</article-title>. <source/>Am. J. Hum. Genet.<year>2012</year>; <volume>90</volume>:<fpage>847</fpage>–<lpage>855</lpage>.<pub-id pub-id-type="pmid">22541559</pub-id></mixed-citation>
</ref>
<ref id="B173">
<label>173.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sekar</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>McDonald</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cuyugan</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Aldrich</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kurdoglu</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Adkins</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Serrano</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Beach</surname><given-names>T.G.</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>D.W.</given-names></name>, <name name-style="western"><surname>Valla</surname><given-names>J.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes</article-title>. <source/>Neurobiol. Aging. <year>2015</year>; <volume>36</volume>:<fpage>583</fpage>–<lpage>591</lpage>.<pub-id pub-id-type="pmid">25448601</pub-id></mixed-citation>
</ref>
<ref id="B174">
<label>174.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Couch</surname><given-names>F.J.</given-names></name>, <name name-style="western"><surname>Kuchenbaecker</surname><given-names>K.B.</given-names></name>, <name name-style="western"><surname>Michailidou</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Mendoza-Fandino</surname><given-names>G.A.</given-names></name>, <name name-style="western"><surname>Nord</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lilyquist</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Olswold</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hallberg</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Agata</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ahsan</surname><given-names>H.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</article-title>. <source/>Nat. Commun.<year>2016</year>; <volume>7</volume>:<fpage>11375</fpage>.<pub-id pub-id-type="pmid">27117709</pub-id></mixed-citation>
</ref>
<ref id="B175">
<label>175.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shaheen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Maddirevula</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ewida</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Alsahli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Abdel-Salam</surname><given-names>G.M.H.</given-names></name>, <name name-style="western"><surname>Zaki</surname><given-names>M.S.</given-names></name>, <name name-style="western"><surname>Tala</surname><given-names>S. Al</given-names></name>, <name name-style="western"><surname>Alhashem</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Softah</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Al-Owain</surname><given-names>M.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Genomic and phenotypic delineation of congenital microcephaly</article-title>. <source/>Genet. Med.<year>2018</year>; <comment>doi:10.1038/s41436-018-0140-3</comment>.</mixed-citation>
</ref>
<ref id="B176">
<label>176.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Edvardson</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Elbaz-Alon</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Jalas</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Matlock</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Labbé</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Shaag</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jackman</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Elpeleg</surname><given-names>O.</given-names></name></person-group>
<article-title>A mutation in the THG1L gene in a family with cerebellar ataxia and developmental delay</article-title>. <source/>Neurogenetics. <year>2016</year>; <volume>17</volume>:<fpage>219</fpage>–<lpage>225</lpage>.<pub-id pub-id-type="pmid">27307223</pub-id></mixed-citation>
</ref>
<ref id="B177">
<label>177.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yew</surname><given-names>T.W.</given-names></name>, <name name-style="western"><surname>McCreight</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Colclough</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ellard</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pearson</surname><given-names>E.R.</given-names></name></person-group>
<article-title>tRNA methyltransferase homologue gene TRMT10A mutation in young adult-onset diabetes with intellectual disability, microcephaly and epilepsy</article-title>. <source/>Diabet. Med.<year>2016</year>; <volume>33</volume>:<fpage>e21</fpage>–<lpage>e25</lpage>.<pub-id pub-id-type="pmid">26526202</pub-id></mixed-citation>
</ref>
<ref id="B178">
<label>178.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zung</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kori</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Burundukov</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ben-Yosef</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Tatoor</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Granot</surname><given-names>E.</given-names></name></person-group>
<article-title>Homozygous deletion of TRMT10A as part of a contiguous gene deletion in a syndrome of failure to thrive, delayed puberty, intellectual disability and diabetes mellitus</article-title>. <source/>Am. J. Med. Genet. A. <year>2015</year>; <volume>167A</volume>:<fpage>3167</fpage>–<lpage>3173</lpage>.<pub-id pub-id-type="pmid">26297882</pub-id></mixed-citation>
</ref>
<ref id="B179">
<label>179.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Narayanan</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ramsey</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Grebe</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Schrauwen</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Szelinger</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Huentelman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Narayanan</surname><given-names>V.</given-names></name><collab>C4RCD Research Group</collab></person-group>
<article-title>Case Report: Compound heterozygous nonsense mutations in TRMT10A are associated with microcephaly, delayed development, and periventricular white matter hyperintensities [version 1; referees: 2 approved]</article-title>. <source/>F1000Research. <year>2015</year>; <volume>4</volume>:<fpage>912</fpage>.<pub-id pub-id-type="pmid">26535115</pub-id></mixed-citation>
</ref>
<ref id="B180">
<label>180.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gillis</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Krishnamohan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yaacov</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Shaag</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jackman</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Elpeleg</surname><given-names>O.</given-names></name></person-group>
<article-title>TRMT10A dysfunction is associated with abnormalities in glucose homeostasis, short stature and microcephaly</article-title>. <source/>J. Med. Genet.<year>2014</year>; <volume>51</volume>:<fpage>581</fpage>–<lpage>586</lpage>.<pub-id pub-id-type="pmid">25053765</pub-id></mixed-citation>
</ref>
<ref id="B181">
<label>181.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>S.</given-names></name></person-group>
<article-title>High expression of N-acetyltransferase 10: a novel independent prognostic marker of worse outcome in patients with hepatocellular carcinoma</article-title>. <source/>Int. J. Clin. Exp. Pathol.<year>2015</year>; <volume>8</volume>:<fpage>14765</fpage>–<lpage>14771</lpage>.<pub-id pub-id-type="pmid">26823802</pub-id></mixed-citation>
</ref>
<ref id="B182">
<label>182.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>X.</given-names></name></person-group>
<article-title>Up regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition</article-title>. <source/>Am. J. Transl. Res.<year>2016</year>; <volume>8</volume>:<fpage>4215</fpage>–<lpage>4223</lpage>.<pub-id pub-id-type="pmid">27830005</pub-id></mixed-citation>
</ref>
<ref id="B183">
<label>183.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Patton</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Bykhovskaya</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Mengesha</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Bertolotto</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Fischel-Ghodsian</surname><given-names>N.</given-names></name></person-group>
<article-title>Mitochondrial myopathy and sideroblastic anemia (MLASA): missense mutation in the pseudouridine synthase 1 (PUS1) gene is associated with the loss of tRNA pseudouridylation</article-title>. <source/>J. Biol. Chem.<year>2005</year>; <volume>280</volume>:<fpage>19823</fpage>–<lpage>19828</lpage>.<pub-id pub-id-type="pmid">15772074</pub-id></mixed-citation>
</ref>
<ref id="B184">
<label>184.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fernandez-Vizarra</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Berardinelli</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Valente</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Tiranti</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Zeviani</surname><given-names>M.</given-names></name></person-group>
<article-title>Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA)</article-title>. <source/>J. Med. Genet.<year>2007</year>; <volume>44</volume>:<fpage>173</fpage>–<lpage>180</lpage>.<pub-id pub-id-type="pmid">17056637</pub-id></mixed-citation>
</ref>
<ref id="B185">
<label>185.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>El-Hattab</surname><given-names>A.W.</given-names></name>, <name name-style="western"><surname>Saleh</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Hashem</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Al-Owain</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Asmari</surname><given-names>A. Al</given-names></name>, <name name-style="western"><surname>Rabei</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Abdelraouf</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hashem</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Alazami</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>N.</given-names></name><etal>et al</etal>.</person-group>
<article-title>ADAT3-related intellectual disability: Further delineation of the phenotype</article-title>. <source/>Am. J. Med. Genet. A. <year>2016</year>; <volume>170A</volume>:<fpage>1142</fpage>–<lpage>1147</lpage>.<pub-id pub-id-type="pmid">26842963</pub-id></mixed-citation>
</ref>
<ref id="B186">
<label>186.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sharkia</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Zalan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jabareen-Masri</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Zahalka</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Mahajnah</surname><given-names>M.</given-names></name></person-group>
<article-title>A new case confirming and expanding the phenotype spectrum of ADAT3-related intellectual disability syndrome</article-title>. <source/>Eur. J. Med. Genet.<year>2018</year>; <volume>S1769-7212</volume>:<fpage>30574</fpage>–<lpage>30583</lpage>.</mixed-citation>
</ref>
<ref id="B187">
<label>187.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Salehi Chaleshtori</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>Miyake</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ahmadvand</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bashti</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Matsumoto</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Noruzinia</surname><given-names>M.</given-names></name></person-group>
<article-title>A novel 8-bp duplication in ADAT3 causes mild intellectual disability</article-title>. <source/>Hum. genome Var.<year>2018</year>; <volume>5</volume>:<fpage>7</fpage>.<pub-id pub-id-type="pmid">29796286</pub-id></mixed-citation>
</ref>
<ref id="B188">
<label>188.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bonnet</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Grégoire</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Brochet</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Raffo</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Leheup</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Jonveaux</surname><given-names>P.</given-names></name></person-group>
<article-title>Pure de-novo 5 Mb duplication at Xp11.22-p11.23 in a male: phenotypic and molecular characterization</article-title>. <source/>J. Hum. Genet.<year>2006</year>; <volume>51</volume>:<fpage>815</fpage>–<lpage>821</lpage>.<pub-id pub-id-type="pmid">16900295</pub-id></mixed-citation>
</ref>
<ref id="B189">
<label>189.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fahiminiya</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Almuriekhi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nawaz</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Staffa</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lepage</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hashim</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Schwartzentruber</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Abu Khadija</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Zaineddin</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Whole exome sequencing unravels disease-causing genes in consanguineous families in Qatar</article-title>. <source/>Clin. Genet.<year>2014</year>; <volume>86</volume>:<fpage>134</fpage>–<lpage>141</lpage>.<pub-id pub-id-type="pmid">24102521</pub-id></mixed-citation>
</ref>
<ref id="B190">
<label>190.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>S.L.</given-names></name>, <name name-style="western"><surname>Coli</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Daly</surname><given-names>I.W.</given-names></name>, <name name-style="western"><surname>Kichula</surname><given-names>E.A.</given-names></name>, <name name-style="western"><surname>Rork</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Volpi</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Ekstein</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>B.Y.</given-names></name></person-group>
<article-title>Familial dysautonomia is caused by mutations of the IKAP gene</article-title>. <source/>Am. J. Hum. Genet.<year>2001</year>; <volume>68</volume>:<fpage>753</fpage>–<lpage>758</lpage>.<pub-id pub-id-type="pmid">11179021</pub-id></mixed-citation>
</ref>
<ref id="B191">
<label>191.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bento-Abreu</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jager</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Swinnen</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Rué</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hendrickx</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Staats</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Taes</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Eykens</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Nonneman</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Elongator subunit 3 (ELP3) modifies ALS through tRNA modification</article-title>. <source/>Hum. Mol. Genet.<year>2018</year>; <volume>27</volume>:<fpage>1276</fpage>–<lpage>1289</lpage>.<pub-id pub-id-type="pmid">29415125</pub-id></mixed-citation>
</ref>
<ref id="B192">
<label>192.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ladang</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Rapino</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Heukamp</surname><given-names>L.C.</given-names></name>, <name name-style="western"><surname>Tharun</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Shostak</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hermand</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Delaunay</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Klevernic</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Jacques</surname><given-names>N.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine</article-title>. <source/>J. Exp. Med.<year>2015</year>; <volume>212</volume>:<fpage>2057</fpage>–<lpage>2075</lpage>.<pub-id pub-id-type="pmid">26527802</pub-id></mixed-citation>
</ref>
<ref id="B193">
<label>193.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Belalcazar</surname><given-names>L.M.</given-names></name>, <name name-style="western"><surname>Papandonatos</surname><given-names>G.D.</given-names></name>, <name name-style="western"><surname>McCaffery</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Peter</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Pajewski</surname><given-names>N.M.</given-names></name>, <name name-style="western"><surname>Erar</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Allred</surname><given-names>N.D.</given-names></name>, <name name-style="western"><surname>Balasubramanyam</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bowden</surname><given-names>D.W.</given-names></name>, <name name-style="western"><surname>Brautbar</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group>
<article-title>A common variant in the CLDN7/ELP5 locus predicts adiponectin change with lifestyle intervention and improved fitness in obese individuals with diabetes</article-title>. <source/>Physiol. Genomics. <year>2015</year>; <volume>47</volume>:<fpage>215</fpage>–<lpage>224</lpage>.<pub-id pub-id-type="pmid">25759378</pub-id></mixed-citation>
</ref>
<ref id="B194">
<label>194.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Close</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Gillard</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ladang</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Papuga</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hawkes</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Chapelle</surname><given-names>J.-P.</given-names></name>, <name name-style="western"><surname>Bouillenne</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Svejstrup</surname><given-names>J.</given-names></name><etal>et al</etal>.</person-group>
<article-title>DERP6 (ELP5) and C3ORF75 (ELP6) regulate tumorigenicity and migration of melanoma cells as subunits of Elongator</article-title>. <source/>J. Biol. Chem.<year>2012</year>; <volume>287</volume>:<fpage>32535</fpage>–<lpage>32545</lpage>.<pub-id pub-id-type="pmid">22854966</pub-id></mixed-citation>
</ref>
<ref id="B195">
<label>195.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Mollet</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Schapiro</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Daugeron</surname><given-names>M.-C.</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Gribouval</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Boyer</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Revy</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Jobst-Schwan</surname><given-names>T.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly</article-title>. <source/>Nat. Genet.<year>2017</year>; <volume>49</volume>:<fpage>1529</fpage>–<lpage>1538</lpage>.<pub-id pub-id-type="pmid">28805828</pub-id></mixed-citation>
</ref>
<ref id="B196">
<label>196.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>P.Z.T.</given-names></name>, <name name-style="western"><surname>Prasad</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Rodriguez Cuellar</surname><given-names>C.I.</given-names></name>, <name name-style="western"><surname>Filler</surname><given-names>G.</given-names></name></person-group>
<article-title>Nephrological and urological complications of homozygous c.974G&gt;A (p.Arg325Gln) OSGEP mutations</article-title>. <source/>Pediatr. Nephrol.<year>2018</year>; <volume>33</volume>:<fpage>2201</fpage>–<lpage>2204</lpage>.<pub-id pub-id-type="pmid">30141175</pub-id></mixed-citation>
</ref>
<ref id="B197">
<label>197.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Hobbs</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Cleves</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Erickson</surname><given-names>S.W.</given-names></name>, <name name-style="western"><surname>MacLeod</surname><given-names>S.L.</given-names></name>, <name name-style="western"><surname>Malik</surname><given-names>S</given-names></name><collab>National Birth Defects Prevention Study</collab></person-group>
<article-title>Genetic variation affects congenital heart defect susceptibility in offspring exposed to maternal tobacco use</article-title>. <source/>Birth Defects Res. A. Clin. Mol. Teratol.<year>2015</year>; <volume>103</volume>:<fpage>834</fpage>–<lpage>842</lpage>.<pub-id pub-id-type="pmid">26033827</pub-id></mixed-citation>
</ref>
<ref id="B198">
<label>198.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>S.</given-names></name></person-group>
<article-title>Alcohol Intake Interacts with CDKAL1, HHEX, and OAS3 genetic variants, associated with the risk of type 2 diabetes by lowering insulin secretion in Korean adults</article-title>. <source/>Alcohol. Clin. Exp. Res.<year>2018</year>; <volume>42</volume>:<fpage>2326</fpage>–<lpage>2336</lpage>.<pub-id pub-id-type="pmid">30207601</pub-id></mixed-citation>
</ref>
<ref id="B199">
<label>199.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nfor</surname><given-names>O.N.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>M.-F.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>C.-T.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W.-H.</given-names></name>, <name name-style="western"><surname>Tantoh</surname><given-names>D.M.</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>S.-Y.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>K.-J.</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>C.-C.</given-names></name>, <name name-style="western"><surname>Debnath</surname><given-names>T.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Body mass index modulates the association between CDKAL1 rs10946398 variant and type 2 diabetes among Taiwanese women</article-title>. <source/>Sci. Rep.<year>2018</year>; <volume>8</volume>:<fpage>13235</fpage>.<pub-id pub-id-type="pmid">30185902</pub-id></mixed-citation>
</ref>
<ref id="B200">
<label>200.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Alcina</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fedetz</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fernández</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Saiz</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Izquierdo</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Lucas</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Leyva</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>García-León</surname><given-names>J.-A.</given-names></name>, <name name-style="western"><surname>Abad-Grau</surname><given-names>M.D.M.</given-names></name>, <name name-style="western"><surname>Alloza</surname><given-names>I.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis</article-title>. <source/>J. Med. Genet.<year>2013</year>; <volume>50</volume>:<fpage>25</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">23160276</pub-id></mixed-citation>
</ref>
<ref id="B201">
<label>201.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wikman</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Nymark</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Väyrynen</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jarmalaite</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kallioniemi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Salmenkivi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Vainio-Siukola</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Husgafvel-Pursiainen</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Knuutila</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>M.</given-names></name><etal>et al</etal>.</person-group>
<article-title>CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer</article-title>. <source/>Genes. Chromosomes Cancer. <year>2005</year>; <volume>42</volume>:<fpage>193</fpage>–<lpage>199</lpage>.<pub-id pub-id-type="pmid">15543620</pub-id></mixed-citation>
</ref>
<ref id="B202">
<label>202.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Trimouille</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lasseaux</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Barat</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Deiller</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Drunat</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rooryck</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Arveiler</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Lacombe</surname><given-names>D.</given-names></name></person-group>
<article-title>Further delineation of the phenotype caused by biallelic variants in the WDR4 gene</article-title>. <source/>Clin. Genet.<year>2018</year>; <volume>93</volume>:<fpage>374</fpage>–<lpage>377</lpage>.<pub-id pub-id-type="pmid">28617965</pub-id></mixed-citation>
</ref>
<ref id="B203">
<label>203.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name></person-group>
<article-title>Speech and language delay in a patient with WDR4 mutations</article-title>. <source/>Eur. J. Med. Genet.<year>2018</year>; <volume>61</volume>:<fpage>468</fpage>–<lpage>472</lpage>.</mixed-citation>
</ref>
<ref id="B204">
<label>204.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Shril</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sinha</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Ashraf</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hermle</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Jobst-Schwan</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Widmeier</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Majmundar</surname><given-names>A.J.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mutations in WDR4 as a new cause of Galloway-Mowat syndrome</article-title>. <source/>Am. J. Med. Genet. A. <year>2018</year>; <volume>176</volume>:<fpage>2460</fpage>–<lpage>2465</lpage>.<pub-id pub-id-type="pmid">30079490</pub-id></mixed-citation>
</ref>
<ref id="B205">
<label>205.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C.-P.</given-names></name>, <name name-style="western"><surname>Chern</surname><given-names>S.-R.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>P.-S.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>S.-W.</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>S.-T.</given-names></name>, <name name-style="western"><surname>Chuang</surname><given-names>T.-Y.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W.-L.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>C.-W.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name></person-group>
<article-title>Prenatal diagnosis of a 3.2-Mb 2p16.1-p15 duplication associated with familial intellectual disability</article-title>. <source/>Taiwan. J. Obstet. Gynecol.<year>2018</year>; <volume>57</volume>:<fpage>578</fpage>–<lpage>582</lpage>.<pub-id pub-id-type="pmid">30122582</pub-id></mixed-citation>
</ref>
<ref id="B206">
<label>206.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Medrano</surname><given-names>L.M.</given-names></name>, <name name-style="western"><surname>Pascual</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Bodas</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>López-Palacios</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Salazar</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Espino-Paisán</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>González-Pérez</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Urcelay</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Mendoza</surname><given-names>J.L.</given-names></name>, <name name-style="western"><surname>Núñez</surname><given-names>C.</given-names></name></person-group>
<article-title>Expression patterns common and unique to ulcerative colitis and celiac disease</article-title>. <source/>Ann. Hum. Genet.<year>2018</year>; <comment>doi:10.1111/ahg.12293</comment>.</mixed-citation>
</ref>
<ref id="B207">
<label>207.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>X.-Y.</given-names></name>, <name name-style="western"><surname>Isaacs</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>S.-Y.</given-names></name></person-group>
<article-title>Roles of mitochondrial 17β-Hydroxysteroid dehydrogenase type 10 in Alzheimer's disease</article-title>. <source/>J. Alzheimers. Dis.<year>2018</year>; <volume>62</volume>:<fpage>665</fpage>–<lpage>673</lpage>.<pub-id pub-id-type="pmid">29480196</pub-id></mixed-citation>
</ref>
<ref id="B208">
<label>208.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Roussel</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Drolet</surname><given-names>M.-C.</given-names></name>, <name name-style="western"><surname>Lavigne</surname><given-names>A.-M.</given-names></name>, <name name-style="western"><surname>Arsenault</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Couet</surname><given-names>J.</given-names></name></person-group>
<article-title>Multiple short-chain dehydrogenases/reductases are regulated in pathological cardiac hypertrophy</article-title>. <source/>FEBS Open Biol.<year>2018</year>; <volume>8</volume>:<fpage>1624</fpage>–<lpage>1635</lpage>.</mixed-citation>
</ref>
<ref id="B209">
<label>209.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Davarniya</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kahrizi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Musante</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Fattahi</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Hosseini</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Maqsoud</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Farajollahi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Wienker</surname><given-names>T.F.</given-names></name>, <name name-style="western"><surname>Ropers</surname><given-names>H.H.</given-names></name><etal>et al</etal>.</person-group>
<article-title>The role of a novel TRMT1 gene mutation and rare GRM1 gene defect in intellectual disability in two azeri families</article-title>. <source/>PLoS One. <year>2015</year>; <volume>10</volume>:<fpage>e0129631</fpage>.<pub-id pub-id-type="pmid">26308914</pub-id></mixed-citation>
</ref>
<ref id="B210">
<label>210.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Najmabadi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Garshasbi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zemojtel</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Abedini</surname><given-names>S.S.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Hosseini</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Behjati</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Haas</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Jamali</surname><given-names>P.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Deep sequencing reveals 50 novel genes for recessive cognitive disorders</article-title>. <source/>Nature. <year>2011</year>; <volume>478</volume>:<fpage>57</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">21937992</pub-id></mixed-citation>
</ref>
<ref id="B211">
<label>211.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Meseguer</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Martínez-Zamora</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>García-Arumí</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Andreu</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Armengod</surname><given-names>M.-E.</given-names></name></person-group>
<article-title>The ROS-sensitive microRNA-9/9* controls the expression of mitochondrial tRNA-modifying enzymes and is involved in the molecular mechanism of MELAS syndrome</article-title>. <source/>Hum. Mol. Genet.<year>2015</year>; <volume>24</volume>:<fpage>167</fpage>–<lpage>184</lpage>.<pub-id pub-id-type="pmid">25149473</pub-id></mixed-citation>
</ref>
<ref id="B212">
<label>212.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>M.-X.</given-names></name></person-group>
<article-title>A human mitochondrial GTP binding protein related to tRNA modification may modulate phenotypic expression of the deafness-associated mitochondrial 12S rRNA mutation</article-title>. <source/>Mol. Cell. Biol.<year>2002</year>; <volume>22</volume>:<fpage>7701</fpage>–<lpage>7711</lpage>.<pub-id pub-id-type="pmid">12370316</pub-id></mixed-citation>
</ref>
<ref id="B213">
<label>213.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Murayama</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Shimura</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Okazaki</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ohtake</surname><given-names>A.</given-names></name></person-group>
<article-title>Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases</article-title>. <source/>J. Hum. Genet.<year>2018</year>; <volume>64</volume>:<fpage>113</fpage>–<lpage>125</lpage>.<pub-id pub-id-type="pmid">30459337</pub-id></mixed-citation>
</ref>
<ref id="B214">
<label>214.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Asano</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>F.-Y.</given-names></name>, <name name-style="western"><surname>Ikeuchi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Numata</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Yamane</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Goto</surname><given-names>T.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease</article-title>. <source/>Nucleic Acids Res.<year>2018</year>; <volume>46</volume>:<fpage>1565</fpage>–<lpage>1583</lpage>.<pub-id pub-id-type="pmid">29390138</pub-id></mixed-citation>
</ref>
<ref id="B215">
<label>215.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>T.W.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>S.-B.</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>H.-S.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S.J.</given-names></name></person-group>
<article-title>Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer</article-title>. <source/>BMC Cancer. <year>2013</year>; <volume>13</volume>:<fpage>502</fpage>.<pub-id pub-id-type="pmid">24160266</pub-id></mixed-citation>
</ref>
<ref id="B216">
<label>216.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ghezzi</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Baruffini</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Haack</surname><given-names>T.B.</given-names></name>, <name name-style="western"><surname>Invernizzi</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Melchionda</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Dallabona</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Strom</surname><given-names>T.M.</given-names></name>, <name name-style="western"><surname>Parini</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Burlina</surname><given-names>A.B.</given-names></name>, <name name-style="western"><surname>Meitinger</surname><given-names>T.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis</article-title>. <source/>Am. J. Hum. Genet.<year>2012</year>; <volume>90</volume>:<fpage>1079</fpage>–<lpage>1087</lpage>.<pub-id pub-id-type="pmid">22608499</pub-id></mixed-citation>
</ref>
<ref id="B217">
<label>217.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Umeda</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yukawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ohya</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shindo</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name></person-group>
<article-title>Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs. Implications for the molecular pathogenesis of human mitochondrial diseases</article-title>. <source/>J. Biol. Chem.<year>2005</year>; <volume>280</volume>:<fpage>1613</fpage>–<lpage>1624</lpage>.<pub-id pub-id-type="pmid">15509579</pub-id></mixed-citation>
</ref>
<ref id="B218">
<label>218.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gaignard</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Gonzales</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ackermann</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Labrune</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Correia</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Therond</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Jacquemin</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Slama</surname><given-names>A.</given-names></name></person-group>
<article-title>Mitochondrial infantile liver disease due to TRMU gene Mutations: Three new cases</article-title>. <source/>JIMD Rep.<year>2013</year>; <volume>11</volume>:<fpage>117</fpage>–<lpage>123</lpage>.<pub-id pub-id-type="pmid">23625533</pub-id></mixed-citation>
</ref>
<ref id="B219">
<label>219.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schara</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>von Kleist-Retzow</surname><given-names>J.-C.</given-names></name>, <name name-style="western"><surname>Lainka</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Gerner</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Pyle</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>P.M.</given-names></name>, <name name-style="western"><surname>Lochmüller</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Czermin</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Abicht</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Holinski-Feder</surname><given-names>E.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations</article-title>. <source/>J. Inherit. Metab. Dis.<year>2011</year>; <volume>34</volume>:<fpage>197</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">21153446</pub-id></mixed-citation>
</ref>
<ref id="B220">
<label>220.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zeharia</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Shaag</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pappo</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Mager-Heckel</surname><given-names>A.-M.</given-names></name>, <name name-style="western"><surname>Saada</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Beinat</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Karicheva</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Mandel</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ofek</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Segel</surname><given-names>R.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Acute infantile liver failure due to mutations in the TRMU gene</article-title>. <source/>Am. J. Hum. Genet.<year>2009</year>; <volume>85</volume>:<fpage>401</fpage>–<lpage>407</lpage>.<pub-id pub-id-type="pmid">19732863</pub-id></mixed-citation>
</ref>
<ref id="B221">
<label>221.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>M.-X.</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Bykhovskaya</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gallo-Teran</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hajek</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Umeda</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Garrido</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Mengesha</surname><given-names>E.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations</article-title>. <source/>Am. J. Hum. Genet.<year>2006</year>; <volume>79</volume>:<fpage>291</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">16826519</pub-id></mixed-citation>
</ref>
<ref id="B222">
<label>222.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Khatami</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rokni-Zadeh</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Mohsen-Pour</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Biglari</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Changi-Ashtiani</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Shahrooei</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Shahani</surname><given-names>T.</given-names></name></person-group>
<article-title>Whole exome sequencing identifies both nuclear and mitochondrial variations in an Iranian family with non-syndromic hearing loss</article-title>. <source/>Mitochondrion. <year>2018</year>; <volume>S1567-7249</volume>:<fpage>30024</fpage>–<lpage>30032</lpage>.</mixed-citation>
</ref>
<ref id="B223">
<label>223.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H.-T.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Hussain</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>C.-H.</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name></person-group>
<article-title>Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information</article-title>. <source/>Oncotarget. <year>2016</year>; <volume>7</volume>:<fpage>36092</fpage>–<lpage>36100</lpage>.<pub-id pub-id-type="pmid">27150055</pub-id></mixed-citation>
</ref>
<ref id="B224">
<label>224.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>J.</given-names></name></person-group>
<article-title>Association of polymorphisms and haplotype in the region of TRIT1, MYCL1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population</article-title>. <source/>Carcinogenesis. <year>2013</year>; <volume>34</volume>:<fpage>1018</fpage>–<lpage>1024</lpage>.<pub-id pub-id-type="pmid">23349019</pub-id></mixed-citation>
</ref>
<ref id="B225">
<label>225.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Spinola</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Galvan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pignatiello</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Conti</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Pastorino</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Nicander</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Paroni</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Dragani</surname><given-names>T.A.</given-names></name></person-group>
<article-title>Identification and functional characterization of the candidate tumor suppressor gene TRIT1 in human lung cancer</article-title>. <source/>Oncogene. <year>2005</year>; <volume>24</volume>:<fpage>5502</fpage>–<lpage>5509</lpage>.<pub-id pub-id-type="pmid">15870694</pub-id></mixed-citation>
</ref>
<ref id="B226">
<label>226.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Palmer</surname><given-names>C.J.</given-names></name>, <name name-style="western"><surname>Bruckner</surname><given-names>R.J.</given-names></name>, <name name-style="western"><surname>Paulo</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Kazak</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Long</surname><given-names>J.Z.</given-names></name>, <name name-style="western"><surname>Mina</surname><given-names>A.I.</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>LeClair</surname><given-names>K.B.</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Cdkal1, a type 2 diabetes susceptibility gene, regulates mitochondrial function in adipose tissue</article-title>. <source/>Mol. Metab.<year>2017</year>; <volume>6</volume>:<fpage>1212</fpage>–<lpage>1225</lpage>.<pub-id pub-id-type="pmid">29031721</pub-id></mixed-citation>
</ref>
<ref id="B227">
<label>227.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>M.-K.</given-names></name>, <name name-style="western"><surname>Uhm</surname><given-names>Y.-K.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.-H.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S.-K.</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>J.-H.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>M.-H.</given-names></name></person-group>
<article-title>Association between CDK5RAP1 polymorphisms and susceptibility to vitiligo in the Korean population</article-title>. <source/>Eur. J. Dermatol.<volume>22</volume>:<fpage>495</fpage>–<lpage>499</lpage>.<pub-id pub-id-type="pmid">22534366</pub-id></mixed-citation>
</ref>
<ref id="B228">
<label>228.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Steinthorsdottir</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Thorleifsson</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Reynisdottir</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Benediktsson</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Jonsdottir</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Walters</surname><given-names>G.B.</given-names></name>, <name name-style="western"><surname>Styrkarsdottir</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Gretarsdottir</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Emilsson</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Ghosh</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group>
<article-title>A variant in CDKAL1 influences insulin response and risk of type 2 diabetes</article-title>. <source/>Nat. Genet.<year>2007</year>; <volume>39</volume>:<fpage>770</fpage>–<lpage>775</lpage>.<pub-id pub-id-type="pmid">17460697</pub-id></mixed-citation>
</ref>
<ref id="B229">
<label>229.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Okamoto</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Koga</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fujii</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Ogawa</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Takata</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Shimamoto</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Tatsuka</surname><given-names>M.</given-names></name></person-group>
<article-title>Frequent increased gene copy number and high protein expression of tRNA (cytosine-5-)-methyltransferase (NSUN2) in human cancers</article-title>. <source/>DNA Cell Biol.<year>2012</year>; <volume>31</volume>:<fpage>660</fpage>–<lpage>671</lpage>.<pub-id pub-id-type="pmid">22136356</pub-id></mixed-citation>
</ref>
<ref id="B230">
<label>230.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Martinez</surname><given-names>F.J.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Blanco</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nickerson</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Gabriel</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Frye</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Al-Gazali</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Gleeson</surname><given-names>J.G.</given-names></name></person-group>
<article-title>Whole exome sequencing identifies a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndrome</article-title>. <source/>J. Med. Genet.<year>2012</year>; <volume>49</volume>:<fpage>380</fpage>–<lpage>385</lpage>.<pub-id pub-id-type="pmid">22577224</pub-id></mixed-citation>
</ref>
<ref id="B231">
<label>231.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Komara</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Al-Shamsi</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Ben-Salem</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>B.R.</given-names></name>, <name name-style="western"><surname>Al-Gazali</surname><given-names>L.</given-names></name></person-group>
<article-title>A novel Single-Nucleotide deletion (c.1020delA) in NSUN2 causes intellectual disability in an emirati child</article-title>. <source/>J. Mol. Neurosci.<year>2015</year>; <volume>57</volume>:<fpage>393</fpage>–<lpage>399</lpage>.<pub-id pub-id-type="pmid">26055038</pub-id></mixed-citation>
</ref>
<ref id="B232">
<label>232.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yi</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Dou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>G.</given-names></name><etal>et al</etal>.</person-group>
<article-title>Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer</article-title>. <source/>Oncotarget. <year>2017</year>; <volume>8</volume>:<fpage>20751</fpage>–<lpage>20765</lpage>.<pub-id pub-id-type="pmid">27447970</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>